#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=A phenome-wide examination of neural and cognitive function This data descriptor outlines a shared neuroimaging dataset from the UCLA Consortium for Neuropsychiatric Phenomics, which focused on understanding the dimensional structure of memory and cognitive control (response inhibition) functions in both healthy individuals (130 subjects) and individuals with neuropsychiatric disorders including schizophrenia (50 subjects), bipolar disorder (49 subjects), and attention deficit/hyperactivity disorder (43 subjects).
1-1	0-1	A	_
1-2	2-14	phenome-wide	_
1-3	15-26	examination	_
1-4	27-29	of	_
1-5	30-36	neural	_
1-6	37-40	and	_
1-7	41-50	cognitive	_
1-8	51-59	function	_
1-9	60-64	This	_
1-10	65-69	data	_
1-11	70-80	descriptor	_
1-12	81-89	outlines	_
1-13	90-91	a	_
1-14	92-98	shared	_
1-15	99-111	neuroimaging	_
1-16	112-119	dataset	_
1-17	120-124	from	_
1-18	125-128	the	_
1-19	129-133	UCLA	_
1-20	134-144	Consortium	_
1-21	145-148	for	_
1-22	149-165	Neuropsychiatric	_
1-23	166-175	Phenomics	_
1-24	176-177	,	_
1-25	178-183	which	_
1-26	184-191	focused	_
1-27	192-194	on	_
1-28	195-208	understanding	_
1-29	209-212	the	_
1-30	213-224	dimensional	_
1-31	225-234	structure	_
1-32	235-237	of	_
1-33	238-244	memory	_
1-34	245-248	and	_
1-35	249-258	cognitive	_
1-36	259-266	control	_
1-37	267-268	(	_
1-38	269-277	response	_
1-39	278-288	inhibition	_
1-40	289-290	)	_
1-41	291-300	functions	_
1-42	301-303	in	_
1-43	304-308	both	_
1-44	309-316	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
1-45	317-328	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
1-46	329-330	(	_
1-47	331-334	130	_
1-48	335-343	subjects	_
1-49	344-345	)	_
1-50	346-349	and	_
1-51	350-361	individuals	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
1-52	362-366	with	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
1-53	367-383	neuropsychiatric	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
1-54	384-393	disorders	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
1-55	394-403	including	_
1-56	404-417	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-57	418-419	(	_
1-58	420-422	50	_
1-59	423-431	subjects	_
1-60	432-433	)	_
1-61	434-435	,	_
1-62	436-443	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
1-63	444-452	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
1-64	453-454	(	_
1-65	455-457	49	_
1-66	458-466	subjects	_
1-67	467-468	)	_
1-68	469-470	,	_
1-69	471-474	and	_
1-70	475-484	attention	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
1-71	485-506	deficit/hyperactivity	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
1-72	507-515	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
1-73	516-517	(	_
1-74	518-520	43	_
1-75	521-529	subjects	_
1-76	530-531	)	_
1-77	532-533	.	_

Text=The dataset includes an extensive set of task-based fMRI assessments, resting fMRI, structural MRI, and high angular resolution diffusion MRI.
2-1	534-537	The	_
2-2	538-545	dataset	_
2-3	546-554	includes	_
2-4	555-557	an	_
2-5	558-567	extensive	_
2-6	568-571	set	_
2-7	572-574	of	_
2-8	575-585	task-based	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
2-9	586-590	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-10	591-602	assessments	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-11	603-604	,	_
2-12	605-612	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-13	613-617	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-14	618-619	,	_
2-15	620-630	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
2-16	631-634	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
2-17	635-636	,	_
2-18	637-640	and	_
2-19	641-645	high	_
2-20	646-653	angular	_
2-21	654-664	resolution	_
2-22	665-674	diffusion	_
2-23	675-678	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
2-24	679-680	.	_

Text=The dataset is shared through the OpenfMRI project, and is formatted according to the Brain Imaging Data Structure (BIDS) standard.
3-1	681-684	The	_
3-2	685-692	dataset	_
3-3	693-695	is	_
3-4	696-702	shared	_
3-5	703-710	through	_
3-6	711-714	the	_
3-7	715-723	OpenfMRI	_
3-8	724-731	project	_
3-9	732-733	,	_
3-10	734-737	and	_
3-11	738-740	is	_
3-12	741-750	formatted	_
3-13	751-760	according	_
3-14	761-763	to	_
3-15	764-767	the	_
3-16	768-773	Brain	_
3-17	774-781	Imaging	_
3-18	782-786	Data	_
3-19	787-796	Structure	_
3-20	797-798	(	_
3-21	799-803	BIDS	_
3-22	804-805	)	_
3-23	806-814	standard	_
3-24	815-816	.	_

Text=Methods Participants Healthy adults were recruited by community advertisements from the Los Angeles area.
4-1	817-824	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
4-2	825-837	Participants	_
4-3	838-845	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-4	846-852	adults	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-5	853-857	were	_
4-6	858-867	recruited	_
4-7	868-870	by	_
4-8	871-880	community	_
4-9	881-895	advertisements	_
4-10	896-900	from	_
4-11	901-904	the	_
4-12	905-908	Los	_
4-13	909-916	Angeles	_
4-14	917-921	area	_
4-15	922-923	.	_

Text=Participants with adult ADHD, bipolar disorder, and schizophrenia were recruited using a patient-oriented strategy involving outreach to local clinics and online portals (separate from the methods used to recruit healthy volunteers).
5-1	924-936	Participants	_
5-2	937-941	with	_
5-3	942-947	adult	_
5-4	948-952	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
5-5	953-954	,	_
5-6	955-962	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
5-7	963-971	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
5-8	972-973	,	_
5-9	974-977	and	_
5-10	978-991	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-11	992-996	were	_
5-12	997-1006	recruited	_
5-13	1007-1012	using	_
5-14	1013-1014	a	_
5-15	1015-1031	patient-oriented	_
5-16	1032-1040	strategy	_
5-17	1041-1050	involving	_
5-18	1051-1059	outreach	_
5-19	1060-1062	to	_
5-20	1063-1068	local	_
5-21	1069-1076	clinics	_
5-22	1077-1080	and	_
5-23	1081-1087	online	_
5-24	1088-1095	portals	_
5-25	1096-1097	(	_
5-26	1098-1106	separate	_
5-27	1107-1111	from	_
5-28	1112-1115	the	_
5-29	1116-1123	methods	_
5-30	1124-1128	used	_
5-31	1129-1131	to	_
5-32	1132-1139	recruit	_
5-33	1140-1147	healthy	_
5-34	1148-1158	volunteers	_
5-35	1159-1160	)	_
5-36	1161-1162	.	_

Text=After receiving a verbal explanation of the study, participants gave written informed consent following procedures approved by the Institutional Review Boards at UCLA and the Los Angeles County Department of Mental Health.
6-1	1163-1168	After	_
6-2	1169-1178	receiving	_
6-3	1179-1180	a	_
6-4	1181-1187	verbal	_
6-5	1188-1199	explanation	_
6-6	1200-1202	of	_
6-7	1203-1206	the	_
6-8	1207-1212	study	_
6-9	1213-1214	,	_
6-10	1215-1227	participants	_
6-11	1228-1232	gave	_
6-12	1233-1240	written	_
6-13	1241-1249	informed	_
6-14	1250-1257	consent	_
6-15	1258-1267	following	_
6-16	1268-1278	procedures	_
6-17	1279-1287	approved	_
6-18	1288-1290	by	_
6-19	1291-1294	the	_
6-20	1295-1308	Institutional	_
6-21	1309-1315	Review	_
6-22	1316-1322	Boards	_
6-23	1323-1325	at	_
6-24	1326-1330	UCLA	_
6-25	1331-1334	and	_
6-26	1335-1338	the	_
6-27	1339-1342	Los	_
6-28	1343-1350	Angeles	_
6-29	1351-1357	County	_
6-30	1358-1368	Department	_
6-31	1369-1371	of	_
6-32	1372-1378	Mental	_
6-33	1379-1385	Health	_
6-34	1386-1387	.	_

Text=For both healthy and patient groups, participants were men or women ages 21–50 years; NIH racial/ethnic category either White, not Hispanic or Latino; or Hispanic or Latino, of any racial group; primary language either English or Spanish; completed at least 8 years of formal education; no significant medical illness; adequate cooperation to complete assessments; visual acuity 20/60 or better; and urinalysis negative for drugs of abuse (Cocaine; Methamphetamine; Morphine; THC; and Benzodiazepines).
7-1	1388-1391	For	_
7-2	1392-1396	both	_
7-3	1397-1404	healthy	_
7-4	1405-1408	and	_
7-5	1409-1416	patient	_
7-6	1417-1423	groups	_
7-7	1424-1425	,	_
7-8	1426-1438	participants	_
7-9	1439-1443	were	_
7-10	1444-1447	men	_
7-11	1448-1450	or	_
7-12	1451-1456	women	_
7-13	1457-1461	ages	_
7-14	1462-1467	21–50	_
7-15	1468-1473	years	_
7-16	1474-1475	;	_
7-17	1476-1479	NIH	_
7-18	1480-1493	racial/ethnic	_
7-19	1494-1502	category	_
7-20	1503-1509	either	_
7-21	1510-1515	White	_
7-22	1516-1517	,	_
7-23	1518-1521	not	_
7-24	1522-1530	Hispanic	_
7-25	1531-1533	or	_
7-26	1534-1540	Latino	_
7-27	1541-1542	;	_
7-28	1543-1545	or	_
7-29	1546-1554	Hispanic	_
7-30	1555-1557	or	_
7-31	1558-1564	Latino	_
7-32	1565-1566	,	_
7-33	1567-1569	of	_
7-34	1570-1573	any	_
7-35	1574-1580	racial	_
7-36	1581-1586	group	_
7-37	1587-1588	;	_
7-38	1589-1596	primary	_
7-39	1597-1605	language	_
7-40	1606-1612	either	_
7-41	1613-1620	English	_
7-42	1621-1623	or	_
7-43	1624-1631	Spanish	_
7-44	1632-1633	;	_
7-45	1634-1643	completed	_
7-46	1644-1646	at	_
7-47	1647-1652	least	_
7-48	1653-1654	8	_
7-49	1655-1660	years	_
7-50	1661-1663	of	_
7-51	1664-1670	formal	_
7-52	1671-1680	education	_
7-53	1681-1682	;	_
7-54	1683-1685	no	_
7-55	1686-1697	significant	_
7-56	1698-1705	medical	_
7-57	1706-1713	illness	_
7-58	1714-1715	;	_
7-59	1716-1724	adequate	_
7-60	1725-1736	cooperation	_
7-61	1737-1739	to	_
7-62	1740-1748	complete	_
7-63	1749-1760	assessments	_
7-64	1761-1762	;	_
7-65	1763-1769	visual	_
7-66	1770-1776	acuity	_
7-67	1777-1782	20/60	_
7-68	1783-1785	or	_
7-69	1786-1792	better	_
7-70	1793-1794	;	_
7-71	1795-1798	and	_
7-72	1799-1809	urinalysis	_
7-73	1810-1818	negative	_
7-74	1819-1822	for	_
7-75	1823-1828	drugs	_
7-76	1829-1831	of	_
7-77	1832-1837	abuse	_
7-78	1838-1839	(	_
7-79	1840-1847	Cocaine	_
7-80	1848-1849	;	_
7-81	1850-1865	Methamphetamine	_
7-82	1866-1867	;	_
7-83	1868-1876	Morphine	_
7-84	1877-1878	;	_
7-85	1879-1882	THC	_
7-86	1883-1884	;	_
7-87	1885-1888	and	_
7-88	1889-1904	Benzodiazepines	_
7-89	1905-1906	)	_
7-90	1907-1908	.	_

Text=Participants in the healthy group were excluded if they had lifetime diagnoses of Schizophrenia or Other Psychotic Disorder, Bipolar I or II Disorder, or Substance Abuse or Dependence (not counting caffeine or nicotine); or current Major Depressive Disorder; suicidality; Anxiety Disorder (Obsessive Compulsive Disorder, Panic Disorder, Generalized Anxiety Disorder, Post-Traumatic Stress Disorder), Attention Deficit Hyperactivity Disorder (ADHD).
8-1	1909-1921	Participants	_
8-2	1922-1924	in	_
8-3	1925-1928	the	_
8-4	1929-1936	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
8-5	1937-1942	group	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
8-6	1943-1947	were	_
8-7	1948-1956	excluded	_
8-8	1957-1959	if	_
8-9	1960-1964	they	_
8-10	1965-1968	had	_
8-11	1969-1977	lifetime	_
8-12	1978-1987	diagnoses	_
8-13	1988-1990	of	_
8-14	1991-2004	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-15	2005-2007	or	_
8-16	2008-2013	Other	_
8-17	2014-2023	Psychotic	_
8-18	2024-2032	Disorder	_
8-19	2033-2034	,	_
8-20	2035-2042	Bipolar	_
8-21	2043-2044	I	_
8-22	2045-2047	or	_
8-23	2048-2050	II	_
8-24	2051-2059	Disorder	_
8-25	2060-2061	,	_
8-26	2062-2064	or	_
8-27	2065-2074	Substance	_
8-28	2075-2080	Abuse	_
8-29	2081-2083	or	_
8-30	2084-2094	Dependence	_
8-31	2095-2096	(	_
8-32	2097-2100	not	_
8-33	2101-2109	counting	_
8-34	2110-2118	caffeine	_
8-35	2119-2121	or	_
8-36	2122-2130	nicotine	_
8-37	2131-2132	)	_
8-38	2133-2134	;	_
8-39	2135-2137	or	_
8-40	2138-2145	current	_
8-41	2146-2151	Major	_
8-42	2152-2162	Depressive	_
8-43	2163-2171	Disorder	_
8-44	2172-2173	;	_
8-45	2174-2185	suicidality	_
8-46	2186-2187	;	_
8-47	2188-2195	Anxiety	_
8-48	2196-2204	Disorder	_
8-49	2205-2206	(	_
8-50	2207-2216	Obsessive	_
8-51	2217-2227	Compulsive	_
8-52	2228-2236	Disorder	_
8-53	2237-2238	,	_
8-54	2239-2244	Panic	_
8-55	2245-2253	Disorder	_
8-56	2254-2255	,	_
8-57	2256-2267	Generalized	_
8-58	2268-2275	Anxiety	_
8-59	2276-2284	Disorder	_
8-60	2285-2286	,	_
8-61	2287-2301	Post-Traumatic	_
8-62	2302-2308	Stress	_
8-63	2309-2317	Disorder	_
8-64	2318-2319	)	_
8-65	2320-2321	,	_
8-66	2322-2331	Attention	_
8-67	2332-2339	Deficit	_
8-68	2340-2353	Hyperactivity	_
8-69	2354-2362	Disorder	_
8-70	2363-2364	(	_
8-71	2365-2369	ADHD	_
8-72	2370-2371	)	_
8-73	2372-2373	.	_

Text=ADHD criteria were assessed using Adult ADHD Interview; healthy participants were screened for sub-threshold ADHD, defined as 4 or more ADHD inattentive or hyperactive/impulsive symptoms in either childhood and adulthood; in addition, they could not have had medication treatment for ADHD within the prior 12 months.
9-1	2374-2378	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-2	2379-2387	criteria	_
9-3	2388-2392	were	_
9-4	2393-2401	assessed	_
9-5	2402-2407	using	_
9-6	2408-2413	Adult	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-7	2414-2418	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-8	2419-2428	Interview	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-9	2429-2430	;	_
9-10	2431-2438	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-11	2439-2451	participants	_
9-12	2452-2456	were	_
9-13	2457-2465	screened	_
9-14	2466-2469	for	_
9-15	2470-2483	sub-threshold	_
9-16	2484-2488	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-17	2489-2490	,	_
9-18	2491-2498	defined	_
9-19	2499-2501	as	_
9-20	2502-2503	4	_
9-21	2504-2506	or	_
9-22	2507-2511	more	_
9-23	2512-2516	ADHD	_
9-24	2517-2528	inattentive	_
9-25	2529-2531	or	_
9-26	2532-2553	hyperactive/impulsive	_
9-27	2554-2562	symptoms	_
9-28	2563-2565	in	_
9-29	2566-2572	either	_
9-30	2573-2582	childhood	_
9-31	2583-2586	and	_
9-32	2587-2596	adulthood	_
9-33	2597-2598	;	_
9-34	2599-2601	in	_
9-35	2602-2610	addition	_
9-36	2611-2612	,	_
9-37	2613-2617	they	_
9-38	2618-2623	could	_
9-39	2624-2627	not	_
9-40	2628-2632	have	_
9-41	2633-2636	had	_
9-42	2637-2647	medication	_
9-43	2648-2657	treatment	_
9-44	2658-2661	for	_
9-45	2662-2666	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
9-46	2667-2673	within	_
9-47	2674-2677	the	_
9-48	2678-2683	prior	_
9-49	2684-2686	12	_
9-50	2687-2693	months	_
9-51	2694-2695	.	_

Text=Each of the patient groups (Schizophrenia, Bipolar Disorder, and ADHD) excluded anyone with one of these other diagnoses; stable medications were permitted for the patients.
10-1	2696-2700	Each	_
10-2	2701-2703	of	_
10-3	2704-2707	the	_
10-4	2708-2715	patient	_
10-5	2716-2722	groups	_
10-6	2723-2724	(	_
10-7	2725-2738	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-8	2739-2740	,	_
10-9	2741-2748	Bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
10-10	2749-2757	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
10-11	2758-2759	,	_
10-12	2760-2763	and	_
10-13	2764-2768	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
10-14	2769-2770	)	_
10-15	2771-2779	excluded	_
10-16	2780-2786	anyone	_
10-17	2787-2791	with	_
10-18	2792-2795	one	_
10-19	2796-2798	of	_
10-20	2799-2804	these	_
10-21	2805-2810	other	_
10-22	2811-2820	diagnoses	_
10-23	2821-2822	;	_
10-24	2823-2829	stable	_
10-25	2830-2841	medications	_
10-26	2842-2846	were	_
10-27	2847-2856	permitted	_
10-28	2857-2860	for	_
10-29	2861-2864	the	_
10-30	2865-2873	patients	_
10-31	2874-2875	.	_

Text=For MRI studies we excluded participants who were left handed, who believed they might be pregnant, or had other contraindications to scanning (e.g., claustrophobia, metal in body, body too large to fit in scanner).
11-1	2876-2879	For	_
11-2	2880-2883	MRI	_
11-3	2884-2891	studies	_
11-4	2892-2894	we	_
11-5	2895-2903	excluded	_
11-6	2904-2916	participants	_
11-7	2917-2920	who	_
11-8	2921-2925	were	_
11-9	2926-2930	left	_
11-10	2931-2937	handed	_
11-11	2938-2939	,	_
11-12	2940-2943	who	_
11-13	2944-2952	believed	_
11-14	2953-2957	they	_
11-15	2958-2963	might	_
11-16	2964-2966	be	_
11-17	2967-2975	pregnant	_
11-18	2976-2977	,	_
11-19	2978-2980	or	_
11-20	2981-2984	had	_
11-21	2985-2990	other	_
11-22	2991-3008	contraindications	_
11-23	3009-3011	to	_
11-24	3012-3020	scanning	_
11-25	3021-3022	(	_
11-26	3023-3027	e.g.	_
11-27	3028-3029	,	_
11-28	3030-3044	claustrophobia	_
11-29	3045-3046	,	_
11-30	3047-3052	metal	_
11-31	3053-3055	in	_
11-32	3056-3060	body	_
11-33	3061-3062	,	_
11-34	3063-3067	body	_
11-35	3068-3071	too	_
11-36	3072-3077	large	_
11-37	3078-3080	to	_
11-38	3081-3084	fit	_
11-39	3085-3087	in	_
11-40	3088-3095	scanner	_
11-41	3096-3097	)	_
11-42	3098-3099	.	_

Text=Diagnoses followed the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition—Text Revision, and were based on the Structured Clinical Interview for DSM-IV (SCID-I) supplemented by the Adult ADHD Interview (a structured interview form derived from the Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version (KSADS-PL)), in order to enable a more detailed characterization of lifetime history of ADHD in adults.
12-1	3100-3109	Diagnoses	_
12-2	3110-3118	followed	_
12-3	3119-3122	the	_
12-4	3123-3133	Diagnostic	_
12-5	3134-3137	and	_
12-6	3138-3149	Statistical	_
12-7	3150-3156	Manual	_
12-8	3157-3159	of	_
12-9	3160-3166	Mental	_
12-10	3167-3176	Disorders	_
12-11	3177-3178	,	_
12-12	3179-3185	Fourth	_
12-13	3186-3198	Edition—Text	_
12-14	3199-3207	Revision	_
12-15	3208-3209	,	_
12-16	3210-3213	and	_
12-17	3214-3218	were	_
12-18	3219-3224	based	_
12-19	3225-3227	on	_
12-20	3228-3231	the	_
12-21	3232-3242	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-22	3243-3251	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-23	3252-3261	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-24	3262-3265	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-25	3266-3272	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-26	3273-3274	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-27	3275-3281	SCID-I	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-28	3282-3283	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
12-29	3284-3296	supplemented	_
12-30	3297-3299	by	_
12-31	3300-3303	the	_
12-32	3304-3309	Adult	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
12-33	3310-3314	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
12-34	3315-3324	Interview	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
12-35	3325-3326	(	_
12-36	3327-3328	a	_
12-37	3329-3339	structured	_
12-38	3340-3349	interview	_
12-39	3350-3354	form	_
12-40	3355-3362	derived	_
12-41	3363-3367	from	_
12-42	3368-3371	the	_
12-43	3372-3378	Kiddie	_
12-44	3379-3387	Schedule	_
12-45	3388-3391	for	_
12-46	3392-3401	Affective	_
12-47	3402-3411	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#ExtrapyramidalDisease
12-48	3412-3415	and	_
12-49	3416-3429	Schizophrenia	_
12-50	3430-3431	,	_
12-51	3432-3439	Present	_
12-52	3440-3443	and	_
12-53	3444-3452	Lifetime	_
12-54	3453-3460	Version	_
12-55	3461-3462	(	_
12-56	3463-3471	KSADS-PL	_
12-57	3472-3473	)	_
12-58	3474-3475	)	_
12-59	3476-3477	,	_
12-60	3478-3480	in	_
12-61	3481-3486	order	_
12-62	3487-3489	to	_
12-63	3490-3496	enable	_
12-64	3497-3498	a	_
12-65	3499-3503	more	_
12-66	3504-3512	detailed	_
12-67	3513-3529	characterization	_
12-68	3530-3532	of	_
12-69	3533-3541	lifetime	_
12-70	3542-3549	history	_
12-71	3550-3552	of	_
12-72	3553-3557	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
12-73	3558-3560	in	_
12-74	3561-3567	adults	_
12-75	3568-3569	.	_

Text=Interviewers/raters were trained to criteria as described elsewhere; in brief minimum standards of acceptable symptom agreement were overall kappa of .75, a kappa specificity of .75 and sensitivity of .75, and .85 kappa for diagnostic accuracy.
13-1	3570-3589	Interviewers/raters	_
13-2	3590-3594	were	_
13-3	3595-3602	trained	_
13-4	3603-3605	to	_
13-5	3606-3614	criteria	_
13-6	3615-3617	as	_
13-7	3618-3627	described	_
13-8	3628-3637	elsewhere	_
13-9	3638-3639	;	_
13-10	3640-3642	in	_
13-11	3643-3648	brief	_
13-12	3649-3656	minimum	_
13-13	3657-3666	standards	_
13-14	3667-3669	of	_
13-15	3670-3680	acceptable	_
13-16	3681-3688	symptom	_
13-17	3689-3698	agreement	_
13-18	3699-3703	were	_
13-19	3704-3711	overall	_
13-20	3712-3717	kappa	_
13-21	3718-3720	of	_
13-22	3721-3724	.75	_
13-23	3725-3726	,	_
13-24	3727-3728	a	_
13-25	3729-3734	kappa	_
13-26	3735-3746	specificity	_
13-27	3747-3749	of	_
13-28	3750-3753	.75	_
13-29	3754-3757	and	_
13-30	3758-3769	sensitivity	_
13-31	3770-3772	of	_
13-32	3773-3776	.75	_
13-33	3777-3778	,	_
13-34	3779-3782	and	_
13-35	3783-3786	.85	_
13-36	3787-3792	kappa	_
13-37	3793-3796	for	_
13-38	3797-3807	diagnostic	_
13-39	3808-3816	accuracy	_
13-40	3817-3818	.	_

Text=Diagnostic and Symptom elicitation skill was also assessed with the SCID Checklist of Interviewer Behaviors and the Symptom Checklist of Interviewer Behaviors.
14-1	3819-3829	Diagnostic	_
14-2	3830-3833	and	_
14-3	3834-3841	Symptom	_
14-4	3842-3853	elicitation	_
14-5	3854-3859	skill	_
14-6	3860-3863	was	_
14-7	3864-3868	also	_
14-8	3869-3877	assessed	_
14-9	3878-3882	with	_
14-10	3883-3886	the	_
14-11	3887-3891	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-12	3892-3901	Checklist	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-13	3902-3904	of	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
14-14	3905-3916	Interviewer	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
14-15	3917-3926	Behaviors	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
14-16	3927-3930	and	_
14-17	3931-3934	the	_
14-18	3935-3942	Symptom	_
14-19	3943-3952	Checklist	http://maven.renci.org/NeuroBridge/neurobridge#QualityOfLifeQuestionnaire
14-20	3953-3955	of	http://maven.renci.org/NeuroBridge/neurobridge#QualityOfLifeQuestionnaire
14-21	3956-3967	Interviewer	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
14-22	3968-3977	Behaviors	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
14-23	3978-3979	.	_

Text=Ongoing quality assurance checks documented kappa above .75 for each rater annually during the course of the study.
15-1	3980-3987	Ongoing	_
15-2	3988-3995	quality	_
15-3	3996-4005	assurance	_
15-4	4006-4012	checks	_
15-5	4013-4023	documented	_
15-6	4024-4029	kappa	_
15-7	4030-4035	above	_
15-8	4036-4039	.75	_
15-9	4040-4043	for	_
15-10	4044-4048	each	_
15-11	4049-4054	rater	_
15-12	4055-4063	annually	_
15-13	4064-4070	during	_
15-14	4071-4074	the	_
15-15	4075-4081	course	_
15-16	4082-4084	of	_
15-17	4085-4088	the	_
15-18	4089-4094	study	_
15-19	4095-4096	.	_

Text=A subset of the larger healthy sample and patient sample took part in two separate fMRI sessions, which each included one hour of behavioral testing and a one-hour scan on the same day.
16-1	4097-4098	A	_
16-2	4099-4105	subset	_
16-3	4106-4108	of	_
16-4	4109-4112	the	_
16-5	4113-4119	larger	_
16-6	4120-4127	healthy	_
16-7	4128-4134	sample	_
16-8	4135-4138	and	_
16-9	4139-4146	patient	_
16-10	4147-4153	sample	_
16-11	4154-4158	took	_
16-12	4159-4163	part	_
16-13	4164-4166	in	_
16-14	4167-4170	two	_
16-15	4171-4179	separate	_
16-16	4180-4184	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
16-17	4185-4193	sessions	_
16-18	4194-4195	,	_
16-19	4196-4201	which	_
16-20	4202-4206	each	_
16-21	4207-4215	included	_
16-22	4216-4219	one	_
16-23	4220-4224	hour	_
16-24	4225-4227	of	_
16-25	4228-4238	behavioral	_
16-26	4239-4246	testing	_
16-27	4247-4250	and	_
16-28	4251-4252	a	_
16-29	4253-4261	one-hour	_
16-30	4262-4266	scan	_
16-31	4267-4269	on	_
16-32	4270-4273	the	_
16-33	4274-4278	same	_
16-34	4279-4282	day	_
16-35	4283-4284	.	_

Text=Eligible English-speaking participants between the ages of 21 and 50 were recruited from the parent study if they successfully completed all previous testing sessions, and they did not meet the following additional exclusion criteria: left-handedness, pregnancy, history of head injury with loss of consciousness or cognitive sequelae, or other contraindications to scanning (e.g., claustrophobia, metal in body).
17-1	4285-4293	Eligible	_
17-2	4294-4310	English-speaking	_
17-3	4311-4323	participants	_
17-4	4324-4331	between	_
17-5	4332-4335	the	_
17-6	4336-4340	ages	_
17-7	4341-4343	of	_
17-8	4344-4346	21	_
17-9	4347-4350	and	_
17-10	4351-4353	50	_
17-11	4354-4358	were	_
17-12	4359-4368	recruited	_
17-13	4369-4373	from	_
17-14	4374-4377	the	_
17-15	4378-4384	parent	_
17-16	4385-4390	study	_
17-17	4391-4393	if	_
17-18	4394-4398	they	_
17-19	4399-4411	successfully	_
17-20	4412-4421	completed	_
17-21	4422-4425	all	_
17-22	4426-4434	previous	_
17-23	4435-4442	testing	_
17-24	4443-4451	sessions	_
17-25	4452-4453	,	_
17-26	4454-4457	and	_
17-27	4458-4462	they	_
17-28	4463-4466	did	_
17-29	4467-4470	not	_
17-30	4471-4475	meet	_
17-31	4476-4479	the	_
17-32	4480-4489	following	_
17-33	4490-4500	additional	_
17-34	4501-4510	exclusion	_
17-35	4511-4519	criteria	_
17-36	4520-4521	:	_
17-37	4522-4537	left-handedness	_
17-38	4538-4539	,	_
17-39	4540-4549	pregnancy	_
17-40	4550-4551	,	_
17-41	4552-4559	history	_
17-42	4560-4562	of	_
17-43	4563-4567	head	_
17-44	4568-4574	injury	_
17-45	4575-4579	with	_
17-46	4580-4584	loss	_
17-47	4585-4587	of	_
17-48	4588-4601	consciousness	_
17-49	4602-4604	or	_
17-50	4605-4614	cognitive	_
17-51	4615-4623	sequelae	_
17-52	4624-4625	,	_
17-53	4626-4628	or	_
17-54	4629-4634	other	_
17-55	4635-4652	contraindications	_
17-56	4653-4655	to	_
17-57	4656-4664	scanning	_
17-58	4665-4666	(	_
17-59	4667-4671	e.g.	_
17-60	4672-4673	,	_
17-61	4674-4688	claustrophobia	_
17-62	4689-4690	,	_
17-63	4691-4696	metal	_
17-64	4697-4699	in	_
17-65	4700-4704	body	_
17-66	4705-4706	)	_
17-67	4707-4708	.	_

Text=The final sample included imaging data for healthy individuals from the community (130 subjects), as well as samples of individuals diagnosed with Schizophrenia (50), Bipolar Disorder (49), and ADHD (43).
18-1	4709-4712	The	_
18-2	4713-4718	final	_
18-3	4719-4725	sample	_
18-4	4726-4734	included	_
18-5	4735-4742	imaging	_
18-6	4743-4747	data	_
18-7	4748-4751	for	_
18-8	4752-4759	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-9	4760-4771	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-10	4772-4776	from	_
18-11	4777-4780	the	_
18-12	4781-4790	community	_
18-13	4791-4792	(	_
18-14	4793-4796	130	_
18-15	4797-4805	subjects	_
18-16	4806-4807	)	_
18-17	4808-4809	,	_
18-18	4810-4812	as	_
18-19	4813-4817	well	_
18-20	4818-4820	as	_
18-21	4821-4828	samples	_
18-22	4829-4831	of	_
18-23	4832-4843	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
18-24	4844-4853	diagnosed	_
18-25	4854-4858	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-26	4859-4872	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-27	4873-4874	(	_
18-28	4875-4877	50	_
18-29	4878-4879	)	_
18-30	4880-4881	,	_
18-31	4882-4889	Bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
18-32	4890-4898	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder
18-33	4899-4900	(	_
18-34	4901-4903	49	_
18-35	4904-4905	)	_
18-36	4906-4907	,	_
18-37	4908-4911	and	_
18-38	4912-4916	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder
18-39	4917-4918	(	_
18-40	4919-4921	43	_
18-41	4922-4923	)	_
18-42	4924-4925	.	_

Text=Diagnostic information is included in Table 1.
19-1	4926-4936	Diagnostic	_
19-2	4937-4948	information	_
19-3	4949-4951	is	_
19-4	4952-4960	included	_
19-5	4961-4963	in	_
19-6	4964-4969	Table	_
19-7	4970-4971	1	_
19-8	4972-4973	.	_

Text=81% of patients had at least one comorbid diagnosis; information on the prevalence comorbid conditions is included in Table 2, and additional details are available from the scid.tsv file in the phenotype directory of the datasets.
20-1	4974-4976	81	_
20-2	4977-4978	%	_
20-3	4979-4981	of	_
20-4	4982-4990	patients	_
20-5	4991-4994	had	_
20-6	4995-4997	at	_
20-7	4998-5003	least	_
20-8	5004-5007	one	_
20-9	5008-5016	comorbid	_
20-10	5017-5026	diagnosis	_
20-11	5027-5028	;	_
20-12	5029-5040	information	_
20-13	5041-5043	on	_
20-14	5044-5047	the	_
20-15	5048-5058	prevalence	_
20-16	5059-5067	comorbid	_
20-17	5068-5078	conditions	_
20-18	5079-5081	is	_
20-19	5082-5090	included	_
20-20	5091-5093	in	_
20-21	5094-5099	Table	_
20-22	5100-5101	2	_
20-23	5102-5103	,	_
20-24	5104-5107	and	_
20-25	5108-5118	additional	_
20-26	5119-5126	details	_
20-27	5127-5130	are	_
20-28	5131-5140	available	_
20-29	5141-5145	from	_
20-30	5146-5149	the	_
20-31	5150-5158	scid.tsv	_
20-32	5159-5163	file	_
20-33	5164-5166	in	_
20-34	5167-5170	the	_
20-35	5171-5180	phenotype	_
20-36	5181-5190	directory	_
20-37	5191-5193	of	_
20-38	5194-5197	the	_
20-39	5198-5206	datasets	_
20-40	5207-5208	.	_

Text=Behavioral assessment Enrolled participants completed extensive neuropsychological testing; these data are included in the phenotype subdirectory, with each data file accompanied by an associated JSON metadata file.
21-1	5209-5219	Behavioral	_
21-2	5220-5230	assessment	_
21-3	5231-5239	Enrolled	_
21-4	5240-5252	participants	_
21-5	5253-5262	completed	_
21-6	5263-5272	extensive	_
21-7	5273-5291	neuropsychological	_
21-8	5292-5299	testing	_
21-9	5300-5301	;	_
21-10	5302-5307	these	_
21-11	5308-5312	data	_
21-12	5313-5316	are	_
21-13	5317-5325	included	_
21-14	5326-5328	in	_
21-15	5329-5332	the	_
21-16	5333-5342	phenotype	_
21-17	5343-5355	subdirectory	_
21-18	5356-5357	,	_
21-19	5358-5362	with	_
21-20	5363-5367	each	_
21-21	5368-5372	data	_
21-22	5373-5377	file	_
21-23	5378-5389	accompanied	_
21-24	5390-5392	by	_
21-25	5393-5395	an	_
21-26	5396-5406	associated	_
21-27	5407-5411	JSON	_
21-28	5412-5420	metadata	_
21-29	5421-5425	file	_
21-30	5426-5427	.	_

Text=The list of tests performed during the behavioral session is presented in Table 3.
22-1	5428-5431	The	_
22-2	5432-5436	list	_
22-3	5437-5439	of	_
22-4	5440-5445	tests	_
22-5	5446-5455	performed	_
22-6	5456-5462	during	_
22-7	5463-5466	the	_
22-8	5467-5477	behavioral	_
22-9	5478-5485	session	_
22-10	5486-5488	is	_
22-11	5489-5498	presented	_
22-12	5499-5501	in	_
22-13	5502-5507	Table	_
22-14	5508-5509	3	_
22-15	5510-5511	.	_

Text=Participants were debriefed and compensated for their time at the end of the final testing session.
23-1	5512-5524	Participants	_
23-2	5525-5529	were	_
23-3	5530-5539	debriefed	_
23-4	5540-5543	and	_
23-5	5544-5555	compensated	_
23-6	5556-5559	for	_
23-7	5560-5565	their	_
23-8	5566-5570	time	_
23-9	5571-5573	at	_
23-10	5574-5577	the	_
23-11	5578-5581	end	_
23-12	5582-5584	of	_
23-13	5585-5588	the	_
23-14	5589-5594	final	_
23-15	5595-5602	testing	_
23-16	5603-5610	session	_
23-17	5611-5612	.	_

Text=Neuroimaging assessment Imaging acquisition MRI data were acquired on one of two 3T Siemens Trio scanners, located at the Ahmanson-Lovelace Brain Mapping Center (Siemens version syngo MR B15) and the Staglin Center for Cognitive Neuroscience (Siemens version syngo MR B17) at UCLA.
24-1	5613-5625	Neuroimaging	_
24-2	5626-5636	assessment	_
24-3	5637-5644	Imaging	_
24-4	5645-5656	acquisition	_
24-5	5657-5660	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
24-6	5661-5665	data	_
24-7	5666-5670	were	_
24-8	5671-5679	acquired	_
24-9	5680-5682	on	_
24-10	5683-5686	one	_
24-11	5687-5689	of	_
24-12	5690-5693	two	_
24-13	5694-5696	3T	http://maven.renci.org/NeuroBridge/neurobridge#Thing
24-14	5697-5704	Siemens	_
24-15	5705-5709	Trio	_
24-16	5710-5718	scanners	_
24-17	5719-5720	,	_
24-18	5721-5728	located	_
24-19	5729-5731	at	_
24-20	5732-5735	the	_
24-21	5736-5753	Ahmanson-Lovelace	_
24-22	5754-5759	Brain	_
24-23	5760-5767	Mapping	_
24-24	5768-5774	Center	_
24-25	5775-5776	(	_
24-26	5777-5784	Siemens	_
24-27	5785-5792	version	_
24-28	5793-5798	syngo	_
24-29	5799-5801	MR	_
24-30	5802-5805	B15	_
24-31	5806-5807	)	_
24-32	5808-5811	and	_
24-33	5812-5815	the	_
24-34	5816-5823	Staglin	_
24-35	5824-5830	Center	_
24-36	5831-5834	for	_
24-37	5835-5844	Cognitive	_
24-38	5845-5857	Neuroscience	_
24-39	5858-5859	(	_
24-40	5860-5867	Siemens	_
24-41	5868-5875	version	_
24-42	5876-5881	syngo	_
24-43	5882-5884	MR	_
24-44	5885-5888	B17	_
24-45	5889-5890	)	_
24-46	5891-5893	at	_
24-47	5894-5898	UCLA	_
24-48	5899-5900	.	_

Text=Functional MRI data were collected using a T2 * -weighted echoplanar imaging (EPI) sequence with the following parameters: slice thickness=4 mm, 34 slices, TR=2 s, TE=30 ms, flip angle=90°, matrix 64×64, FOV=192 mm, oblique slice orientation.
25-1	5901-5911	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
25-2	5912-5915	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
25-3	5916-5920	data	_
25-4	5921-5925	were	_
25-5	5926-5935	collected	_
25-6	5936-5941	using	_
25-7	5942-5943	a	_
25-8	5944-5946	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-9	5947-5948	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-10	5949-5958	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-11	5959-5969	echoplanar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-12	5970-5977	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-13	5978-5979	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-14	5980-5983	EPI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-15	5984-5985	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-16	5986-5994	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
25-17	5995-5999	with	_
25-18	6000-6003	the	_
25-19	6004-6013	following	_
25-20	6014-6024	parameters	_
25-21	6025-6026	:	_
25-22	6027-6032	slice	_
25-23	6033-6044	thickness=4	_
25-24	6045-6047	mm	_
25-25	6048-6049	,	_
25-26	6050-6052	34	_
25-27	6053-6059	slices	_
25-28	6060-6061	,	_
25-29	6062-6066	TR=2	_
25-30	6067-6068	s	_
25-31	6069-6070	,	_
25-32	6071-6076	TE=30	_
25-33	6077-6079	ms	_
25-34	6080-6081	,	_
25-35	6082-6086	flip	_
25-36	6087-6096	angle=90°	_
25-37	6097-6098	,	_
25-38	6099-6105	matrix	_
25-39	6106-6111	64×64	_
25-40	6112-6113	,	_
25-41	6114-6121	FOV=192	_
25-42	6122-6124	mm	_
25-43	6125-6126	,	_
25-44	6127-6134	oblique	_
25-45	6135-6140	slice	_
25-46	6141-6152	orientation	_
25-47	6153-6154	.	_

Text=Additionally, a T2-weighted matched-bandwidth high-resolution anatomical scan (with the same slice prescription as the fMRI scan) and MPRAGE were collected; the former is not included in the current data distribution.
26-1	6155-6167	Additionally	_
26-2	6168-6169	,	_
26-3	6170-6171	a	_
26-4	6172-6183	T2-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
26-5	6184-6201	matched-bandwidth	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
26-6	6202-6217	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
26-7	6218-6228	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
26-8	6229-6233	scan	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
26-9	6234-6235	(	_
26-10	6236-6240	with	_
26-11	6241-6244	the	_
26-12	6245-6249	same	_
26-13	6250-6255	slice	_
26-14	6256-6268	prescription	_
26-15	6269-6271	as	_
26-16	6272-6275	the	_
26-17	6276-6280	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
26-18	6281-6285	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
26-19	6286-6287	)	_
26-20	6288-6291	and	_
26-21	6292-6298	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
26-22	6299-6303	were	_
26-23	6304-6313	collected	_
26-24	6314-6315	;	_
26-25	6316-6319	the	_
26-26	6320-6326	former	_
26-27	6327-6329	is	_
26-28	6330-6333	not	_
26-29	6334-6342	included	_
26-30	6343-6345	in	_
26-31	6346-6349	the	_
26-32	6350-6357	current	_
26-33	6358-6362	data	_
26-34	6363-6375	distribution	_
26-35	6376-6377	.	_

Text=The parameters for the high-resolution scan were: 4 mm slices, TR/TE=5000/34 ms, 4 averages, matrix=128×128, 90 degree flip angle.
27-1	6378-6381	The	_
27-2	6382-6392	parameters	_
27-3	6393-6396	for	_
27-4	6397-6400	the	_
27-5	6401-6416	high-resolution	_
27-6	6417-6421	scan	_
27-7	6422-6426	were	_
27-8	6427-6428	:	_
27-9	6429-6430	4	_
27-10	6431-6433	mm	_
27-11	6434-6440	slices	_
27-12	6441-6442	,	_
27-13	6443-6456	TR/TE=5000/34	_
27-14	6457-6459	ms	_
27-15	6460-6461	,	_
27-16	6462-6463	4	_
27-17	6464-6472	averages	_
27-18	6473-6474	,	_
27-19	6475-6489	matrix=128×128	_
27-20	6490-6491	,	_
27-21	6492-6494	90	_
27-22	6495-6501	degree	_
27-23	6502-6506	flip	_
27-24	6507-6512	angle	_
27-25	6513-6514	.	_

Text=The parameters for MPRAGE were the following: TR=1.9 s, TE=2.26 ms, FOV=250 mm, matrix=256×256, sagittal plane, slice thickness=1 mm, 176 slices.
28-1	6515-6518	The	_
28-2	6519-6529	parameters	_
28-3	6530-6533	for	_
28-4	6534-6540	MPRAGE	_
28-5	6541-6545	were	_
28-6	6546-6549	the	_
28-7	6550-6559	following	_
28-8	6560-6561	:	_
28-9	6562-6568	TR=1.9	_
28-10	6569-6570	s	_
28-11	6571-6572	,	_
28-12	6573-6580	TE=2.26	_
28-13	6581-6583	ms	_
28-14	6584-6585	,	_
28-15	6586-6593	FOV=250	_
28-16	6594-6596	mm	_
28-17	6597-6598	,	_
28-18	6599-6613	matrix=256×256	_
28-19	6614-6615	,	_
28-20	6616-6624	sagittal	_
28-21	6625-6630	plane	_
28-22	6631-6632	,	_
28-23	6633-6638	slice	_
28-24	6639-6650	thickness=1	_
28-25	6651-6653	mm	_
28-26	6654-6655	,	_
28-27	6656-6659	176	_
28-28	6660-6666	slices	_
28-29	6667-6668	.	_

Text=Diffusion weighted imaging (DWI) data were collected using an echo-planar sequence with parameters: 64 directions, 2 mm slices, TR/TE=9000/93 ms, 1 average, 96×96 matrix, 90 degree flip angle, axial slices, b=1000 s/mm2.
29-1	6669-6678	Diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-2	6679-6687	weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-3	6688-6695	imaging	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-4	6696-6697	(	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-5	6698-6701	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-6	6702-6703	)	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging
29-7	6704-6708	data	_
29-8	6709-6713	were	_
29-9	6714-6723	collected	_
29-10	6724-6729	using	_
29-11	6730-6732	an	_
29-12	6733-6744	echo-planar	_
29-13	6745-6753	sequence	_
29-14	6754-6758	with	_
29-15	6759-6769	parameters	_
29-16	6770-6771	:	_
29-17	6772-6774	64	_
29-18	6775-6785	directions	_
29-19	6786-6787	,	_
29-20	6788-6789	2	_
29-21	6790-6792	mm	_
29-22	6793-6799	slices	_
29-23	6800-6801	,	_
29-24	6802-6815	TR/TE=9000/93	_
29-25	6816-6818	ms	_
29-26	6819-6820	,	_
29-27	6821-6822	1	_
29-28	6823-6830	average	_
29-29	6831-6832	,	_
29-30	6833-6838	96×96	_
29-31	6839-6845	matrix	_
29-32	6846-6847	,	_
29-33	6848-6850	90	_
29-34	6851-6857	degree	_
29-35	6858-6862	flip	_
29-36	6863-6868	angle	_
29-37	6869-6870	,	_
29-38	6871-6876	axial	_
29-39	6877-6883	slices	_
29-40	6884-6885	,	_
29-41	6886-6892	b=1000	_
29-42	6893-6898	s/mm2	_
29-43	6899-6900	.	_

Text=Subjects participated in two scanning sessions (‘ A ’ and ‘ B ’) in a counterbalanced fashion.
30-1	6901-6909	Subjects	_
30-2	6910-6922	participated	_
30-3	6923-6925	in	_
30-4	6926-6929	two	_
30-5	6930-6938	scanning	_
30-6	6939-6947	sessions	_
30-7	6948-6949	(	_
30-8	6950-6951	‘	_
30-9	6952-6953	A	_
30-10	6954-6955	’	_
30-11	6956-6959	and	_
30-12	6960-6961	‘	_
30-13	6962-6963	B	_
30-14	6964-6965	’	_
30-15	6966-6967	)	_
30-16	6968-6970	in	_
30-17	6971-6972	a	_
30-18	6973-6988	counterbalanced	_
30-19	6989-6996	fashion	_
30-20	6997-6998	.	_

Text=Session A included: localizer, MPRAGE, DWI, Matched Bandwidth Hires, Balloon Analog Risk Task, and Paired-associate Memory Task.
31-1	6999-7006	Session	_
31-2	7007-7008	A	_
31-3	7009-7017	included	_
31-4	7018-7019	:	_
31-5	7020-7029	localizer	_
31-6	7030-7031	,	_
31-7	7032-7038	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
31-8	7039-7040	,	_
31-9	7041-7044	DWI	_
31-10	7045-7046	,	_
31-11	7047-7054	Matched	_
31-12	7055-7064	Bandwidth	http://maven.renci.org/NeuroBridge/neurobridge#HandednessQuestionnaire
31-13	7065-7070	Hires	http://maven.renci.org/NeuroBridge/neurobridge#HandednessQuestionnaire
31-14	7071-7072	,	_
31-15	7073-7080	Balloon	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
31-16	7081-7087	Analog	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
31-17	7088-7092	Risk	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
31-18	7093-7097	Task	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
31-19	7098-7099	,	_
31-20	7100-7103	and	_
31-21	7104-7120	Paired-associate	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
31-22	7121-7127	Memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
31-23	7128-7132	Task	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
31-24	7133-7134	.	_

Text=Session B included: localizer, Matched Bandwidth Hires, Resting State, Breath Hold Task, Stop Signal Task, Spatial Capacity working memory task (SCAP), and Task Switching Task.
32-1	7135-7142	Session	_
32-2	7143-7144	B	_
32-3	7145-7153	included	_
32-4	7154-7155	:	_
32-5	7156-7165	localizer	_
32-6	7166-7167	,	_
32-7	7168-7175	Matched	_
32-8	7176-7185	Bandwidth	_
32-9	7186-7191	Hires	http://maven.renci.org/NeuroBridge/neurobridge#Depression
32-10	7192-7193	,	_
32-11	7194-7201	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-12	7202-7207	State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-13	7208-7209	,	_
32-14	7210-7216	Breath	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
32-15	7217-7221	Hold	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
32-16	7222-7226	Task	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
32-17	7227-7228	,	_
32-18	7229-7233	Stop	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-19	7234-7240	Signal	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-20	7241-7245	Task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-21	7246-7247	,	_
32-22	7248-7255	Spatial	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-23	7256-7264	Capacity	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-24	7265-7272	working	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-25	7273-7279	memory	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-26	7280-7284	task	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-27	7285-7286	(	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-28	7287-7291	SCAP	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-29	7292-7293	)	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
32-30	7294-7295	,	_
32-31	7296-7299	and	_
32-32	7300-7304	Task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
32-33	7305-7314	Switching	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
32-34	7315-7319	Task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
32-35	7320-7321	.	_

Text=Resting fMRI The resting fMRI scan lasted 304 s. Participants were asked to remain relaxed and keep their eyes open; they were not presented any stimuli or asked to respond during the scan.
33-1	7322-7329	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-2	7330-7334	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-3	7335-7338	The	_
33-4	7339-7346	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-5	7347-7351	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-6	7352-7356	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-7	7357-7363	lasted	_
33-8	7364-7367	304	_
33-9	7368-7370	s.	_
33-10	7371-7383	Participants	_
33-11	7384-7388	were	_
33-12	7389-7394	asked	_
33-13	7395-7397	to	_
33-14	7398-7404	remain	_
33-15	7405-7412	relaxed	_
33-16	7413-7416	and	_
33-17	7417-7421	keep	_
33-18	7422-7427	their	_
33-19	7428-7432	eyes	_
33-20	7433-7437	open	_
33-21	7438-7439	;	_
33-22	7440-7444	they	_
33-23	7445-7449	were	_
33-24	7450-7453	not	_
33-25	7454-7463	presented	_
33-26	7464-7467	any	_
33-27	7468-7475	stimuli	_
33-28	7476-7478	or	_
33-29	7479-7484	asked	_
33-30	7485-7487	to	_
33-31	7488-7495	respond	_
33-32	7496-7502	during	_
33-33	7503-7506	the	_
33-34	7507-7511	scan	_
33-35	7512-7513	.	_

Text=Task fMRI For each task described below, all participants received brief training on each task immediately before scanning.
34-1	7514-7518	Task	_
34-2	7519-7523	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-3	7524-7527	For	_
34-4	7528-7532	each	_
34-5	7533-7537	task	_
34-6	7538-7547	described	_
34-7	7548-7553	below	_
34-8	7554-7555	,	_
34-9	7556-7559	all	_
34-10	7560-7572	participants	_
34-11	7573-7581	received	_
34-12	7582-7587	brief	_
34-13	7588-7596	training	_
34-14	7597-7599	on	_
34-15	7600-7604	each	_
34-16	7605-7609	task	_
34-17	7610-7621	immediately	_
34-18	7622-7628	before	_
34-19	7629-7637	scanning	_
34-20	7638-7639	.	_

Text=Each participant viewed the task stimuli through MRI-compatible goggles, responded with his or her right hand on an MR-compatible button box in the scanner, and performed one run of each task while in the scanner.
35-1	7640-7644	Each	_
35-2	7645-7656	participant	_
35-3	7657-7663	viewed	_
35-4	7664-7667	the	_
35-5	7668-7672	task	_
35-6	7673-7680	stimuli	_
35-7	7681-7688	through	_
35-8	7689-7703	MRI-compatible	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
35-9	7704-7711	goggles	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
35-10	7712-7713	,	_
35-11	7714-7723	responded	_
35-12	7724-7728	with	_
35-13	7729-7732	his	_
35-14	7733-7735	or	_
35-15	7736-7739	her	_
35-16	7740-7745	right	_
35-17	7746-7750	hand	_
35-18	7751-7753	on	_
35-19	7754-7756	an	_
35-20	7757-7770	MR-compatible	_
35-21	7771-7777	button	_
35-22	7778-7781	box	_
35-23	7782-7784	in	_
35-24	7785-7788	the	_
35-25	7789-7796	scanner	_
35-26	7797-7798	,	_
35-27	7799-7802	and	_
35-28	7803-7812	performed	_
35-29	7813-7816	one	_
35-30	7817-7820	run	_
35-31	7821-7823	of	_
35-32	7824-7828	each	_
35-33	7829-7833	task	_
35-34	7834-7839	while	_
35-35	7840-7842	in	_
35-36	7843-7846	the	_
35-37	7847-7854	scanner	_
35-38	7855-7856	.	_

Text=The presentation and timing of all stimuli and response events were achieved using Matlab (Mathworks) and the Psychtoolbox (www.psychtoolbox.org) on an Apple Powerbook.
36-1	7857-7860	The	_
36-2	7861-7873	presentation	_
36-3	7874-7877	and	_
36-4	7878-7884	timing	_
36-5	7885-7887	of	_
36-6	7888-7891	all	_
36-7	7892-7899	stimuli	_
36-8	7900-7903	and	_
36-9	7904-7912	response	_
36-10	7913-7919	events	_
36-11	7920-7924	were	_
36-12	7925-7933	achieved	_
36-13	7934-7939	using	_
36-14	7940-7946	Matlab	_
36-15	7947-7948	(	_
36-16	7949-7958	Mathworks	_
36-17	7959-7960	)	_
36-18	7961-7964	and	_
36-19	7965-7968	the	_
36-20	7969-7981	Psychtoolbox	_
36-21	7982-7983	(	_
36-22	7984-8004	www.psychtoolbox.org	_
36-23	8005-8006	)	_
36-24	8007-8009	on	_
36-25	8010-8012	an	_
36-26	8013-8018	Apple	_
36-27	8019-8028	Powerbook	_
36-28	8029-8030	.	_

Text=Code for all tasks (except for Paired Associate Memory) is available at https: //poldracklab.stanford.edu/software.
37-1	8031-8035	Code	_
37-2	8036-8039	for	_
37-3	8040-8043	all	_
37-4	8044-8049	tasks	_
37-5	8050-8051	(	_
37-6	8052-8058	except	_
37-7	8059-8062	for	_
37-8	8063-8069	Paired	_
37-9	8070-8079	Associate	_
37-10	8080-8086	Memory	_
37-11	8087-8088	)	_
37-12	8089-8091	is	_
37-13	8092-8101	available	_
37-14	8102-8104	at	_
37-15	8105-8110	https	_
37-16	8111-8112	:	_
37-17	8113-8148	//poldracklab.stanford.edu/software	_
37-18	8149-8150	.	_

Text=Balloon analog risk task In this task, participants were allowed to pump a series of virtual green (experimental) and white (control) balloons.
38-1	8151-8158	Balloon	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
38-2	8159-8165	analog	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
38-3	8166-8170	risk	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
38-4	8171-8175	task	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask
38-5	8176-8178	In	_
38-6	8179-8183	this	_
38-7	8184-8188	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
38-8	8189-8190	,	_
38-9	8191-8203	participants	_
38-10	8204-8208	were	_
38-11	8209-8216	allowed	_
38-12	8217-8219	to	_
38-13	8220-8224	pump	_
38-14	8225-8226	a	_
38-15	8227-8233	series	_
38-16	8234-8236	of	_
38-17	8237-8244	virtual	_
38-18	8245-8250	green	_
38-19	8251-8252	(	_
38-20	8253-8265	experimental	_
38-21	8266-8267	)	_
38-22	8268-8271	and	_
38-23	8272-8277	white	_
38-24	8278-8279	(	_
38-25	8280-8287	control	_
38-26	8288-8289	)	_
38-27	8290-8298	balloons	_
38-28	8299-8300	.	_

Text=On each trial, participants chose to pump the balloon or cash out and collect their accumulated earnings for that round.
39-1	8301-8303	On	_
39-2	8304-8308	each	_
39-3	8309-8314	trial	_
39-4	8315-8316	,	_
39-5	8317-8329	participants	_
39-6	8330-8335	chose	_
39-7	8336-8338	to	_
39-8	8339-8343	pump	_
39-9	8344-8347	the	_
39-10	8348-8355	balloon	_
39-11	8356-8358	or	_
39-12	8359-8363	cash	_
39-13	8364-8367	out	_
39-14	8368-8371	and	_
39-15	8372-8379	collect	_
39-16	8380-8385	their	_
39-17	8386-8397	accumulated	_
39-18	8398-8406	earnings	_
39-19	8407-8410	for	_
39-20	8411-8415	that	_
39-21	8416-8421	round	_
39-22	8422-8423	.	_

Text=For experimental balloons, after a trial in which the participant successfully pumped the balloon (meaning it did not result in an explosion), an image of a larger balloon was presented, the participant earned 5 points, and was able to pump again or cash out.
40-1	8424-8427	For	_
40-2	8428-8440	experimental	_
40-3	8441-8449	balloons	_
40-4	8450-8451	,	_
40-5	8452-8457	after	_
40-6	8458-8459	a	_
40-7	8460-8465	trial	_
40-8	8466-8468	in	_
40-9	8469-8474	which	_
40-10	8475-8478	the	_
40-11	8479-8490	participant	_
40-12	8491-8503	successfully	_
40-13	8504-8510	pumped	_
40-14	8511-8514	the	_
40-15	8515-8522	balloon	_
40-16	8523-8524	(	_
40-17	8525-8532	meaning	_
40-18	8533-8535	it	_
40-19	8536-8539	did	_
40-20	8540-8543	not	_
40-21	8544-8550	result	_
40-22	8551-8553	in	_
40-23	8554-8556	an	_
40-24	8557-8566	explosion	_
40-25	8567-8568	)	_
40-26	8569-8570	,	_
40-27	8571-8573	an	_
40-28	8574-8579	image	_
40-29	8580-8582	of	_
40-30	8583-8584	a	_
40-31	8585-8591	larger	_
40-32	8592-8599	balloon	_
40-33	8600-8603	was	_
40-34	8604-8613	presented	_
40-35	8614-8615	,	_
40-36	8616-8619	the	_
40-37	8620-8631	participant	_
40-38	8632-8638	earned	_
40-39	8639-8640	5	_
40-40	8641-8647	points	_
40-41	8648-8649	,	_
40-42	8650-8653	and	_
40-43	8654-8657	was	_
40-44	8658-8662	able	_
40-45	8663-8665	to	_
40-46	8666-8670	pump	_
40-47	8671-8676	again	_
40-48	8677-8679	or	_
40-49	8680-8684	cash	_
40-50	8685-8688	out	_
40-51	8689-8690	.	_

Text=After a trial in which the participant chose to cash out, the participant ’ s accumulated earnings for that round were displayed and the task moved onto the next round.
41-1	8691-8696	After	_
41-2	8697-8698	a	_
41-3	8699-8704	trial	_
41-4	8705-8707	in	_
41-5	8708-8713	which	_
41-6	8714-8717	the	_
41-7	8718-8729	participant	_
41-8	8730-8735	chose	_
41-9	8736-8738	to	_
41-10	8739-8743	cash	_
41-11	8744-8747	out	_
41-12	8748-8749	,	_
41-13	8750-8753	the	_
41-14	8754-8765	participant	_
41-15	8766-8767	’	_
41-16	8768-8769	s	_
41-17	8770-8781	accumulated	_
41-18	8782-8790	earnings	_
41-19	8791-8794	for	_
41-20	8795-8799	that	_
41-21	8800-8805	round	_
41-22	8806-8810	were	_
41-23	8811-8820	displayed	_
41-24	8821-8824	and	_
41-25	8825-8828	the	_
41-26	8829-8833	task	_
41-27	8834-8839	moved	_
41-28	8840-8844	onto	_
41-29	8845-8848	the	_
41-30	8849-8853	next	_
41-31	8854-8859	round	_
41-32	8860-8861	.	_

Text=On an explosion trial (necessarily following a pump trial), an exploded balloon was presented, the participant received no points for that round, and the task moved onto the next round.
42-1	8862-8864	On	_
42-2	8865-8867	an	_
42-3	8868-8877	explosion	_
42-4	8878-8883	trial	_
42-5	8884-8885	(	_
42-6	8886-8897	necessarily	_
42-7	8898-8907	following	_
42-8	8908-8909	a	_
42-9	8910-8914	pump	_
42-10	8915-8920	trial	_
42-11	8921-8922	)	_
42-12	8923-8924	,	_
42-13	8925-8927	an	_
42-14	8928-8936	exploded	_
42-15	8937-8944	balloon	_
42-16	8945-8948	was	_
42-17	8949-8958	presented	_
42-18	8959-8960	,	_
42-19	8961-8964	the	_
42-20	8965-8976	participant	_
42-21	8977-8985	received	_
42-22	8986-8988	no	_
42-23	8989-8995	points	_
42-24	8996-8999	for	_
42-25	9000-9004	that	_
42-26	9005-9010	round	_
42-27	9011-9012	,	_
42-28	9013-9016	and	_
42-29	9017-9020	the	_
42-30	9021-9025	task	_
42-31	9026-9031	moved	_
42-32	9032-9036	onto	_
42-33	9037-9040	the	_
42-34	9041-9045	next	_
42-35	9046-9051	round	_
42-36	9052-9053	.	_

Text=In this version of the BART, balloons exploded randomly on a number drawn from a uniform distribution over numbers of pumps, with 12 maximum pumps possible before an explosion or end of a round.
43-1	9054-9056	In	_
43-2	9057-9061	this	_
43-3	9062-9069	version	_
43-4	9070-9072	of	_
43-5	9073-9076	the	_
43-6	9077-9081	BART	_
43-7	9082-9083	,	_
43-8	9084-9092	balloons	_
43-9	9093-9101	exploded	_
43-10	9102-9110	randomly	_
43-11	9111-9113	on	_
43-12	9114-9115	a	_
43-13	9116-9122	number	_
43-14	9123-9128	drawn	_
43-15	9129-9133	from	_
43-16	9134-9135	a	_
43-17	9136-9143	uniform	_
43-18	9144-9156	distribution	_
43-19	9157-9161	over	_
43-20	9162-9169	numbers	_
43-21	9170-9172	of	_
43-22	9173-9178	pumps	_
43-23	9179-9180	,	_
43-24	9181-9185	with	_
43-25	9186-9188	12	_
43-26	9189-9196	maximum	_
43-27	9197-9202	pumps	_
43-28	9203-9211	possible	_
43-29	9212-9218	before	_
43-30	9219-9221	an	_
43-31	9222-9231	explosion	_
43-32	9232-9234	or	_
43-33	9235-9238	end	_
43-34	9239-9241	of	_
43-35	9242-9243	a	_
43-36	9244-9249	round	_
43-37	9250-9251	.	_

Text=Thus, participants experienced the probability as non-stationary, as the likelihood of a loss event increased with each trial in a round and as no information was provided to subjects about the probability of explosion.
44-1	9252-9256	Thus	_
44-2	9257-9258	,	_
44-3	9259-9271	participants	_
44-4	9272-9283	experienced	_
44-5	9284-9287	the	_
44-6	9288-9299	probability	_
44-7	9300-9302	as	_
44-8	9303-9317	non-stationary	_
44-9	9318-9319	,	_
44-10	9320-9322	as	_
44-11	9323-9326	the	_
44-12	9327-9337	likelihood	_
44-13	9338-9340	of	_
44-14	9341-9342	a	_
44-15	9343-9347	loss	_
44-16	9348-9353	event	_
44-17	9354-9363	increased	_
44-18	9364-9368	with	_
44-19	9369-9373	each	_
44-20	9374-9379	trial	_
44-21	9380-9382	in	_
44-22	9383-9384	a	_
44-23	9385-9390	round	_
44-24	9391-9394	and	_
44-25	9395-9397	as	_
44-26	9398-9400	no	_
44-27	9401-9412	information	_
44-28	9413-9416	was	_
44-29	9417-9425	provided	_
44-30	9426-9428	to	_
44-31	9429-9437	subjects	_
44-32	9438-9443	about	_
44-33	9444-9447	the	_
44-34	9448-9459	probability	_
44-35	9460-9462	of	_
44-36	9463-9472	explosion	_
44-37	9473-9474	.	_

Text=Subjects were not informed regarding the maximum pumps possible before an explosion or end of the round.
45-1	9475-9483	Subjects	_
45-2	9484-9488	were	_
45-3	9489-9492	not	_
45-4	9493-9501	informed	_
45-5	9502-9511	regarding	_
45-6	9512-9515	the	_
45-7	9516-9523	maximum	_
45-8	9524-9529	pumps	_
45-9	9530-9538	possible	_
45-10	9539-9545	before	_
45-11	9546-9548	an	_
45-12	9549-9558	explosion	_
45-13	9559-9561	or	_
45-14	9562-9565	end	_
45-15	9566-9568	of	_
45-16	9569-9572	the	_
45-17	9573-9578	round	_
45-18	9579-9580	.	_

Text=Participants also responded to control balloons, which increased in size on successive trials, but which neither resulted in points nor exploded.
46-1	9581-9593	Participants	_
46-2	9594-9598	also	_
46-3	9599-9608	responded	_
46-4	9609-9611	to	_
46-5	9612-9619	control	_
46-6	9620-9628	balloons	_
46-7	9629-9630	,	_
46-8	9631-9636	which	_
46-9	9637-9646	increased	_
46-10	9647-9649	in	_
46-11	9650-9654	size	_
46-12	9655-9657	on	_
46-13	9658-9668	successive	_
46-14	9669-9675	trials	_
46-15	9676-9677	,	_
46-16	9678-9681	but	_
46-17	9682-9687	which	_
46-18	9688-9695	neither	_
46-19	9696-9704	resulted	_
46-20	9705-9707	in	_
46-21	9708-9714	points	_
46-22	9715-9718	nor	_
46-23	9719-9727	exploded	_
46-24	9728-9729	.	_

Text=For both balloons (green and white), the balloon would disappear from the screen once the participant responded, and each balloon trial was separated by a jittered delay.
47-1	9730-9733	For	_
47-2	9734-9738	both	_
47-3	9739-9747	balloons	_
47-4	9748-9749	(	_
47-5	9750-9755	green	_
47-6	9756-9759	and	_
47-7	9760-9765	white	_
47-8	9766-9767	)	_
47-9	9768-9769	,	_
47-10	9770-9773	the	_
47-11	9774-9781	balloon	_
47-12	9782-9787	would	_
47-13	9788-9797	disappear	_
47-14	9798-9802	from	_
47-15	9803-9806	the	_
47-16	9807-9813	screen	_
47-17	9814-9818	once	_
47-18	9819-9822	the	_
47-19	9823-9834	participant	_
47-20	9835-9844	responded	_
47-21	9845-9846	,	_
47-22	9847-9850	and	_
47-23	9851-9855	each	_
47-24	9856-9863	balloon	_
47-25	9864-9869	trial	_
47-26	9870-9873	was	_
47-27	9874-9883	separated	_
47-28	9884-9886	by	_
47-29	9887-9888	a	_
47-30	9889-9897	jittered	_
47-31	9898-9903	delay	_
47-32	9904-9905	.	_

Text=An outcome trial (following a cash-out trial or an explosion) was displayed for a fixed duration of 2 s. Each trial was separated by a blank screen that was presented for a variable duration (1–2 s, average 1.5 s); each round was separated by a blank screen that was presented for variable duration (1–12 s, average 4 s).
48-1	9906-9908	An	_
48-2	9909-9916	outcome	_
48-3	9917-9922	trial	_
48-4	9923-9924	(	_
48-5	9925-9934	following	_
48-6	9935-9936	a	_
48-7	9937-9945	cash-out	_
48-8	9946-9951	trial	_
48-9	9952-9954	or	_
48-10	9955-9957	an	_
48-11	9958-9967	explosion	_
48-12	9968-9969	)	_
48-13	9970-9973	was	_
48-14	9974-9983	displayed	_
48-15	9984-9987	for	_
48-16	9988-9989	a	_
48-17	9990-9995	fixed	_
48-18	9996-10004	duration	_
48-19	10005-10007	of	_
48-20	10008-10009	2	_
48-21	10010-10012	s.	_
48-22	10013-10017	Each	_
48-23	10018-10023	trial	_
48-24	10024-10027	was	_
48-25	10028-10037	separated	_
48-26	10038-10040	by	_
48-27	10041-10042	a	_
48-28	10043-10048	blank	_
48-29	10049-10055	screen	_
48-30	10056-10060	that	_
48-31	10061-10064	was	_
48-32	10065-10074	presented	_
48-33	10075-10078	for	_
48-34	10079-10080	a	_
48-35	10081-10089	variable	_
48-36	10090-10098	duration	_
48-37	10099-10100	(	_
48-38	10101-10104	1–2	_
48-39	10105-10106	s	_
48-40	10107-10108	,	_
48-41	10109-10116	average	_
48-42	10117-10120	1.5	_
48-43	10121-10122	s	_
48-44	10123-10124	)	_
48-45	10125-10126	;	_
48-46	10127-10131	each	_
48-47	10132-10137	round	_
48-48	10138-10141	was	_
48-49	10142-10151	separated	_
48-50	10152-10154	by	_
48-51	10155-10156	a	_
48-52	10157-10162	blank	_
48-53	10163-10169	screen	_
48-54	10170-10174	that	_
48-55	10175-10178	was	_
48-56	10179-10188	presented	_
48-57	10189-10192	for	_
48-58	10193-10201	variable	_
48-59	10202-10210	duration	_
48-60	10211-10212	(	_
48-61	10213-10217	1–12	_
48-62	10218-10219	s	_
48-63	10220-10221	,	_
48-64	10222-10229	average	_
48-65	10230-10231	4	_
48-66	10232-10233	s	_
48-67	10234-10235	)	_
48-68	10236-10237	.	_

Text=The task performed in the scanner was self-paced, but the task was programmed such that participants saw approximately 30 virtual balloons, with an approximate run time of 9 min.
49-1	10238-10241	The	_
49-2	10242-10246	task	_
49-3	10247-10256	performed	_
49-4	10257-10259	in	_
49-5	10260-10263	the	_
49-6	10264-10271	scanner	_
49-7	10272-10275	was	_
49-8	10276-10286	self-paced	_
49-9	10287-10288	,	_
49-10	10289-10292	but	_
49-11	10293-10296	the	_
49-12	10297-10301	task	_
49-13	10302-10305	was	_
49-14	10306-10316	programmed	_
49-15	10317-10321	such	_
49-16	10322-10326	that	_
49-17	10327-10339	participants	_
49-18	10340-10343	saw	_
49-19	10344-10357	approximately	_
49-20	10358-10360	30	_
49-21	10361-10368	virtual	_
49-22	10369-10377	balloons	_
49-23	10378-10379	,	_
49-24	10380-10384	with	_
49-25	10385-10387	an	_
49-26	10388-10399	approximate	_
49-27	10400-10403	run	_
49-28	10404-10408	time	_
49-29	10409-10411	of	_
49-30	10412-10413	9	_
49-31	10414-10417	min	_
49-32	10418-10419	.	_

Text=Each successful pump was worth 5 points, but participants did not collect their earnings at the end of the scan.
50-1	10420-10424	Each	_
50-2	10425-10435	successful	_
50-3	10436-10440	pump	_
50-4	10441-10444	was	_
50-5	10445-10450	worth	_
50-6	10451-10452	5	_
50-7	10453-10459	points	_
50-8	10460-10461	,	_
50-9	10462-10465	but	_
50-10	10466-10478	participants	_
50-11	10479-10482	did	_
50-12	10483-10486	not	_
50-13	10487-10494	collect	_
50-14	10495-10500	their	_
50-15	10501-10509	earnings	_
50-16	10510-10512	at	_
50-17	10513-10516	the	_
50-18	10517-10520	end	_
50-19	10521-10523	of	_
50-20	10524-10527	the	_
50-21	10528-10532	scan	_
50-22	10533-10534	.	_

Text=Paired-associate memory task In this task, two scans were performed to assess declarative memory encoding and retrieval, respectively.
51-1	10535-10551	Paired-associate	_
51-2	10552-10558	memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
51-3	10559-10563	task	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
51-4	10564-10566	In	_
51-5	10567-10571	this	_
51-6	10572-10576	task	_
51-7	10577-10578	,	_
51-8	10579-10582	two	_
51-9	10583-10588	scans	_
51-10	10589-10593	were	_
51-11	10594-10603	performed	_
51-12	10604-10606	to	_
51-13	10607-10613	assess	_
51-14	10614-10625	declarative	_
51-15	10626-10632	memory	_
51-16	10633-10641	encoding	_
51-17	10642-10645	and	_
51-18	10646-10655	retrieval	_
51-19	10656-10657	,	_
51-20	10658-10670	respectively	_
51-21	10671-10672	.	_

Text=The first scan consisted of a block of 64 encoding trials.
52-1	10673-10676	The	_
52-2	10677-10682	first	_
52-3	10683-10687	scan	_
52-4	10688-10697	consisted	_
52-5	10698-10700	of	_
52-6	10701-10702	a	_
52-7	10703-10708	block	_
52-8	10709-10711	of	_
52-9	10712-10714	64	_
52-10	10715-10723	encoding	_
52-11	10724-10730	trials	_
52-12	10731-10732	.	_

Text=Forty of the encoding trials were ‘ memory ’ trials and 24 were ‘ control ’ trials.
53-1	10733-10738	Forty	_
53-2	10739-10741	of	_
53-3	10742-10745	the	_
53-4	10746-10754	encoding	_
53-5	10755-10761	trials	_
53-6	10762-10766	were	_
53-7	10767-10768	‘	_
53-8	10769-10775	memory	_
53-9	10776-10777	’	_
53-10	10778-10784	trials	_
53-11	10785-10788	and	_
53-12	10789-10791	24	_
53-13	10792-10796	were	_
53-14	10797-10798	‘	_
53-15	10799-10806	control	_
53-16	10807-10808	’	_
53-17	10809-10815	trials	_
53-18	10816-10817	.	_

Text=During memory trials, first, two words appeared for 1 s, one on each side of the screen.
54-1	10818-10824	During	_
54-2	10825-10831	memory	_
54-3	10832-10838	trials	_
54-4	10839-10840	,	_
54-5	10841-10846	first	_
54-6	10847-10848	,	_
54-7	10849-10852	two	_
54-8	10853-10858	words	_
54-9	10859-10867	appeared	_
54-10	10868-10871	for	_
54-11	10872-10873	1	_
54-12	10874-10875	s	_
54-13	10876-10877	,	_
54-14	10878-10881	one	_
54-15	10882-10884	on	_
54-16	10885-10889	each	_
54-17	10890-10894	side	_
54-18	10895-10897	of	_
54-19	10898-10901	the	_
54-20	10902-10908	screen	_
54-21	10909-10910	.	_

Text=Then, line drawings of two objects that matched the words appeared above the words and they were presented together for 3 more seconds, for a total of 4 s per trial.
55-1	10911-10915	Then	_
55-2	10916-10917	,	_
55-3	10918-10922	line	_
55-4	10923-10931	drawings	_
55-5	10932-10934	of	_
55-6	10935-10938	two	_
55-7	10939-10946	objects	_
55-8	10947-10951	that	_
55-9	10952-10959	matched	_
55-10	10960-10963	the	_
55-11	10964-10969	words	_
55-12	10970-10978	appeared	_
55-13	10979-10984	above	_
55-14	10985-10988	the	_
55-15	10989-10994	words	_
55-16	10995-10998	and	_
55-17	10999-11003	they	_
55-18	11004-11008	were	_
55-19	11009-11018	presented	_
55-20	11019-11027	together	_
55-21	11028-11031	for	_
55-22	11032-11033	3	_
55-23	11034-11038	more	_
55-24	11039-11046	seconds	_
55-25	11047-11048	,	_
55-26	11049-11052	for	_
55-27	11053-11054	a	_
55-28	11055-11060	total	_
55-29	11061-11063	of	_
55-30	11064-11065	4	_
55-31	11066-11067	s	_
55-32	11068-11071	per	_
55-33	11072-11077	trial	_
55-34	11078-11079	.	_

Text=One of the objects was drawn in black and white, and one object drawn using a single color (e.g., orange).
56-1	11080-11083	One	_
56-2	11084-11086	of	_
56-3	11087-11090	the	_
56-4	11091-11098	objects	_
56-5	11099-11102	was	_
56-6	11103-11108	drawn	_
56-7	11109-11111	in	_
56-8	11112-11117	black	_
56-9	11118-11121	and	_
56-10	11122-11127	white	_
56-11	11128-11129	,	_
56-12	11130-11133	and	_
56-13	11134-11137	one	_
56-14	11138-11144	object	_
56-15	11145-11150	drawn	_
56-16	11151-11156	using	_
56-17	11157-11158	a	_
56-18	11159-11165	single	_
56-19	11166-11171	color	_
56-20	11172-11173	(	_
56-21	11174-11178	e.g.	_
56-22	11179-11180	,	_
56-23	11181-11187	orange	_
56-24	11188-11189	)	_
56-25	11190-11191	.	_

Text=For control trials, pairs of scrambled stimuli, one black and white and one colored, appeared for 2 s. The subject indicated by button press which side the colored object was on.
57-1	11192-11195	For	_
57-2	11196-11203	control	_
57-3	11204-11210	trials	_
57-4	11211-11212	,	_
57-5	11213-11218	pairs	_
57-6	11219-11221	of	_
57-7	11222-11231	scrambled	_
57-8	11232-11239	stimuli	_
57-9	11240-11241	,	_
57-10	11242-11245	one	_
57-11	11246-11251	black	_
57-12	11252-11255	and	_
57-13	11256-11261	white	_
57-14	11262-11265	and	_
57-15	11266-11269	one	_
57-16	11270-11277	colored	_
57-17	11278-11279	,	_
57-18	11280-11288	appeared	_
57-19	11289-11292	for	_
57-20	11293-11294	2	_
57-21	11295-11297	s.	_
57-22	11298-11301	The	_
57-23	11302-11309	subject	_
57-24	11310-11319	indicated	_
57-25	11320-11322	by	_
57-26	11323-11329	button	_
57-27	11330-11335	press	_
57-28	11336-11341	which	_
57-29	11342-11346	side	_
57-30	11347-11350	the	_
57-31	11351-11358	colored	_
57-32	11359-11365	object	_
57-33	11366-11369	was	_
57-34	11370-11372	on	_
57-35	11373-11374	.	_

Text=Subjects were instructed to remember the objects and the relationship between the objects.
58-1	11375-11383	Subjects	_
58-2	11384-11388	were	_
58-3	11389-11399	instructed	_
58-4	11400-11402	to	_
58-5	11403-11411	remember	_
58-6	11412-11415	the	_
58-7	11416-11423	objects	_
58-8	11424-11427	and	_
58-9	11428-11431	the	_
58-10	11432-11444	relationship	_
58-11	11445-11452	between	_
58-12	11453-11456	the	_
58-13	11457-11464	objects	_
58-14	11465-11466	.	_

Text=The trial types were intermixed.
59-1	11467-11470	The	_
59-2	11471-11476	trial	_
59-3	11477-11482	types	_
59-4	11483-11487	were	_
59-5	11488-11498	intermixed	_
59-6	11499-11500	.	_

Text=In total, the encoding run included 242 TRs of which 104 (42.9%) were active task, and the ITI between trials was jittered.
60-1	11501-11503	In	_
60-2	11504-11509	total	_
60-3	11510-11511	,	_
60-4	11512-11515	the	_
60-5	11516-11524	encoding	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
60-6	11525-11528	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
60-7	11529-11537	included	_
60-8	11538-11541	242	_
60-9	11542-11545	TRs	_
60-10	11546-11548	of	_
60-11	11549-11554	which	_
60-12	11555-11558	104	_
60-13	11559-11560	(	_
60-14	11561-11565	42.9	_
60-15	11566-11567	%	_
60-16	11568-11569	)	_
60-17	11570-11574	were	_
60-18	11575-11581	active	_
60-19	11582-11586	task	_
60-20	11587-11588	,	_
60-21	11589-11592	and	_
60-22	11593-11596	the	_
60-23	11597-11600	ITI	_
60-24	11601-11608	between	_
60-25	11609-11615	trials	_
60-26	11616-11619	was	_
60-27	11620-11628	jittered	_
60-28	11629-11630	.	_

Text=The encoding run, in total, was 8.07 min long.
61-1	11631-11634	The	_
61-2	11635-11643	encoding	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
61-3	11644-11647	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
61-4	11648-11649	,	_
61-5	11650-11652	in	_
61-6	11653-11658	total	_
61-7	11659-11660	,	_
61-8	11661-11664	was	_
61-9	11665-11669	8.07	_
61-10	11670-11673	min	_
61-11	11674-11678	long	_
61-12	11679-11680	.	_

Text=During the retrieval scan there were 104 total trials: 24 control trials, 40 correct trials, and 40 incorrect trials, each trial was 3 s long.
62-1	11681-11687	During	_
62-2	11688-11691	the	_
62-3	11692-11701	retrieval	_
62-4	11702-11706	scan	_
62-5	11707-11712	there	_
62-6	11713-11717	were	_
62-7	11718-11721	104	_
62-8	11722-11727	total	_
62-9	11728-11734	trials	_
62-10	11735-11736	:	_
62-11	11737-11739	24	_
62-12	11740-11747	control	_
62-13	11748-11754	trials	_
62-14	11755-11756	,	_
62-15	11757-11759	40	_
62-16	11760-11767	correct	_
62-17	11768-11774	trials	_
62-18	11775-11776	,	_
62-19	11777-11780	and	_
62-20	11781-11783	40	_
62-21	11784-11793	incorrect	_
62-22	11794-11800	trials	_
62-23	11801-11802	,	_
62-24	11803-11807	each	_
62-25	11808-11813	trial	_
62-26	11814-11817	was	_
62-27	11818-11819	3	_
62-28	11820-11821	s	_
62-29	11822-11826	long	_
62-30	11827-11828	.	_

Text=The retrieval task required the subjects to look at a pair of objects and rate their confidence in their memory of the pairing.
63-1	11829-11832	The	_
63-2	11833-11842	retrieval	_
63-3	11843-11847	task	_
63-4	11848-11856	required	_
63-5	11857-11860	the	_
63-6	11861-11869	subjects	_
63-7	11870-11872	to	_
63-8	11873-11877	look	_
63-9	11878-11880	at	_
63-10	11881-11882	a	_
63-11	11883-11887	pair	_
63-12	11888-11890	of	_
63-13	11891-11898	objects	_
63-14	11899-11902	and	_
63-15	11903-11907	rate	_
63-16	11908-11913	their	_
63-17	11914-11924	confidence	_
63-18	11925-11927	in	_
63-19	11928-11933	their	_
63-20	11934-11940	memory	_
63-21	11941-11943	of	_
63-22	11944-11947	the	_
63-23	11948-11955	pairing	_
63-24	11956-11957	.	_

Text=There were 4 possible response options ranging from ‘ Sure correct ’ to ‘ Sure incorrect ’, allowing the responses to be analyzed as a spectrum or binarized into yes/no type responses.
64-1	11958-11963	There	_
64-2	11964-11968	were	_
64-3	11969-11970	4	_
64-4	11971-11979	possible	_
64-5	11980-11988	response	_
64-6	11989-11996	options	_
64-7	11997-12004	ranging	_
64-8	12005-12009	from	_
64-9	12010-12011	‘	_
64-10	12012-12016	Sure	_
64-11	12017-12024	correct	_
64-12	12025-12026	’	_
64-13	12027-12029	to	_
64-14	12030-12031	‘	_
64-15	12032-12036	Sure	_
64-16	12037-12046	incorrect	_
64-17	12047-12048	’	_
64-18	12049-12050	,	_
64-19	12051-12059	allowing	_
64-20	12060-12063	the	_
64-21	12064-12073	responses	_
64-22	12074-12076	to	_
64-23	12077-12079	be	_
64-24	12080-12088	analyzed	_
64-25	12089-12091	as	_
64-26	12092-12093	a	_
64-27	12094-12102	spectrum	_
64-28	12103-12105	or	_
64-29	12106-12115	binarized	_
64-30	12116-12120	into	_
64-31	12121-12127	yes/no	_
64-32	12128-12132	type	_
64-33	12133-12142	responses	_
64-34	12143-12144	.	_

Text=During control trials, on one side of the screen was one of the four retrieval confidence response options ‘ sure correct ’, ‘ maybe correct ’, ‘ maybe incorrect ’, or ‘ sure incorrect ’.
65-1	12145-12151	During	_
65-2	12152-12159	control	_
65-3	12160-12166	trials	_
65-4	12167-12168	,	_
65-5	12169-12171	on	_
65-6	12172-12175	one	_
65-7	12176-12180	side	_
65-8	12181-12183	of	_
65-9	12184-12187	the	_
65-10	12188-12194	screen	_
65-11	12195-12198	was	_
65-12	12199-12202	one	_
65-13	12203-12205	of	_
65-14	12206-12209	the	_
65-15	12210-12214	four	_
65-16	12215-12224	retrieval	_
65-17	12225-12235	confidence	_
65-18	12236-12244	response	_
65-19	12245-12252	options	_
65-20	12253-12254	‘	_
65-21	12255-12259	sure	_
65-22	12260-12267	correct	_
65-23	12268-12269	’	_
65-24	12270-12271	,	_
65-25	12272-12273	‘	_
65-26	12274-12279	maybe	_
65-27	12280-12287	correct	_
65-28	12288-12289	’	_
65-29	12290-12291	,	_
65-30	12292-12293	‘	_
65-31	12294-12299	maybe	_
65-32	12300-12309	incorrect	_
65-33	12310-12311	’	_
65-34	12312-12313	,	_
65-35	12314-12316	or	_
65-36	12317-12318	‘	_
65-37	12319-12323	sure	_
65-38	12324-12333	incorrect	_
65-39	12334-12335	’	_
65-40	12336-12337	.	_

Text=On the other side of the screen was ‘ xxxx ’.
66-1	12338-12340	On	_
66-2	12341-12344	the	_
66-3	12345-12350	other	_
66-4	12351-12355	side	_
66-5	12356-12358	of	_
66-6	12359-12362	the	_
66-7	12363-12369	screen	_
66-8	12370-12373	was	_
66-9	12374-12375	‘	_
66-10	12376-12380	xxxx	_
66-11	12381-12382	’	_
66-12	12383-12384	.	_

Text=Subjects were asked to press the button (1–4) that corresponded to the response option displayed (for example, a response of 1 if ‘ sure correct ’ appeared).
67-1	12385-12393	Subjects	_
67-2	12394-12398	were	_
67-3	12399-12404	asked	_
67-4	12405-12407	to	_
67-5	12408-12413	press	_
67-6	12414-12417	the	_
67-7	12418-12424	button	_
67-8	12425-12426	(	_
67-9	12427-12430	1–4	_
67-10	12431-12432	)	_
67-11	12433-12437	that	_
67-12	12438-12450	corresponded	_
67-13	12451-12453	to	_
67-14	12454-12457	the	_
67-15	12458-12466	response	_
67-16	12467-12473	option	_
67-17	12474-12483	displayed	_
67-18	12484-12485	(	_
67-19	12486-12489	for	_
67-20	12490-12497	example	_
67-21	12498-12499	,	_
67-22	12500-12501	a	_
67-23	12502-12510	response	_
67-24	12511-12513	of	_
67-25	12514-12515	1	_
67-26	12516-12518	if	_
67-27	12519-12520	‘	_
67-28	12521-12525	sure	_
67-29	12526-12533	correct	_
67-30	12534-12535	’	_
67-31	12536-12544	appeared	_
67-32	12545-12546	)	_
67-33	12547-12548	.	_

Text=In the 40 correct trials, items were shown paired as they had been at encoding.
68-1	12549-12551	In	_
68-2	12552-12555	the	_
68-3	12556-12558	40	_
68-4	12559-12566	correct	_
68-5	12567-12573	trials	_
68-6	12574-12575	,	_
68-7	12576-12581	items	_
68-8	12582-12586	were	_
68-9	12587-12592	shown	_
68-10	12593-12599	paired	_
68-11	12600-12602	as	_
68-12	12603-12607	they	_
68-13	12608-12611	had	_
68-14	12612-12616	been	_
68-15	12617-12619	at	_
68-16	12620-12628	encoding	_
68-17	12629-12630	.	_

Text=During the 40 incorrect trials items were shown paired differently than they were at encoding; some individual objects had been displayed as part of pairs during encoding, but at retrieval were paired with different objects.
69-1	12631-12637	During	_
69-2	12638-12641	the	_
69-3	12642-12644	40	_
69-4	12645-12654	incorrect	_
69-5	12655-12661	trials	_
69-6	12662-12667	items	_
69-7	12668-12672	were	_
69-8	12673-12678	shown	_
69-9	12679-12685	paired	_
69-10	12686-12697	differently	_
69-11	12698-12702	than	_
69-12	12703-12707	they	_
69-13	12708-12712	were	_
69-14	12713-12715	at	_
69-15	12716-12724	encoding	_
69-16	12725-12726	;	_
69-17	12727-12731	some	_
69-18	12732-12742	individual	_
69-19	12743-12750	objects	_
69-20	12751-12754	had	_
69-21	12755-12759	been	_
69-22	12760-12769	displayed	_
69-23	12770-12772	as	_
69-24	12773-12777	part	_
69-25	12778-12780	of	_
69-26	12781-12786	pairs	_
69-27	12787-12793	during	_
69-28	12794-12802	encoding	_
69-29	12803-12804	,	_
69-30	12805-12808	but	_
69-31	12809-12811	at	_
69-32	12812-12821	retrieval	_
69-33	12822-12826	were	_
69-34	12827-12833	paired	_
69-35	12834-12838	with	_
69-36	12839-12848	different	_
69-37	12849-12856	objects	_
69-38	12857-12858	.	_

Text=The retrieval scan consisted of 268 TRs, of which 156 (58.2%) were active task, and was 8.93 min long.
70-1	12859-12862	The	_
70-2	12863-12872	retrieval	_
70-3	12873-12877	scan	_
70-4	12878-12887	consisted	_
70-5	12888-12890	of	_
70-6	12891-12894	268	_
70-7	12895-12898	TRs	_
70-8	12899-12900	,	_
70-9	12901-12903	of	_
70-10	12904-12909	which	_
70-11	12910-12913	156	_
70-12	12914-12915	(	_
70-13	12916-12920	58.2	_
70-14	12921-12922	%	_
70-15	12923-12924	)	_
70-16	12925-12929	were	_
70-17	12930-12936	active	_
70-18	12937-12941	task	_
70-19	12942-12943	,	_
70-20	12944-12947	and	_
70-21	12948-12951	was	_
70-22	12952-12956	8.93	_
70-23	12957-12960	min	_
70-24	12961-12965	long	_
70-25	12966-12967	.	_

Text=Spatial working memory task During the spatial delayed response task (or, spatial capacity task—SCAP), subjects were shown a target array of 1, 3, 5 or 7 yellow circles positioned pseudorandomly around a central fixation cross.
71-1	12968-12975	Spatial	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
71-2	12976-12983	working	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
71-3	12984-12990	memory	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
71-4	12991-12995	task	http://maven.renci.org/NeuroBridge/neurobridge#SpatialWorkingMemory
71-5	12996-13002	During	_
71-6	13003-13006	the	_
71-7	13007-13014	spatial	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
71-8	13015-13022	delayed	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
71-9	13023-13031	response	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
71-10	13032-13036	task	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
71-11	13037-13038	(	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
71-12	13039-13041	or	_
71-13	13042-13043	,	_
71-14	13044-13051	spatial	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
71-15	13052-13060	capacity	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
71-16	13061-13070	task—SCAP	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
71-17	13071-13072	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
71-18	13073-13074	,	_
71-19	13075-13083	subjects	_
71-20	13084-13088	were	_
71-21	13089-13094	shown	_
71-22	13095-13096	a	_
71-23	13097-13103	target	_
71-24	13104-13109	array	_
71-25	13110-13112	of	_
71-26	13113-13114	1	_
71-27	13115-13116	,	_
71-28	13117-13118	3	_
71-29	13119-13120	,	_
71-30	13121-13122	5	_
71-31	13123-13125	or	_
71-32	13126-13127	7	_
71-33	13128-13134	yellow	_
71-34	13135-13142	circles	_
71-35	13143-13153	positioned	_
71-36	13154-13168	pseudorandomly	_
71-37	13169-13175	around	_
71-38	13176-13177	a	_
71-39	13178-13185	central	_
71-40	13186-13194	fixation	_
71-41	13195-13200	cross	_
71-42	13201-13202	.	_

Text=After a delay, subjects were shown a single green circle and were required to indicate whether that circle was in the same position as one of the target circles had been.
72-1	13203-13208	After	_
72-2	13209-13210	a	_
72-3	13211-13216	delay	_
72-4	13217-13218	,	_
72-5	13219-13227	subjects	_
72-6	13228-13232	were	_
72-7	13233-13238	shown	_
72-8	13239-13240	a	_
72-9	13241-13247	single	_
72-10	13248-13253	green	_
72-11	13254-13260	circle	_
72-12	13261-13264	and	_
72-13	13265-13269	were	_
72-14	13270-13278	required	_
72-15	13279-13281	to	_
72-16	13282-13290	indicate	_
72-17	13291-13298	whether	_
72-18	13299-13303	that	_
72-19	13304-13310	circle	_
72-20	13311-13314	was	_
72-21	13315-13317	in	_
72-22	13318-13321	the	_
72-23	13322-13326	same	_
72-24	13327-13335	position	_
72-25	13336-13338	as	_
72-26	13339-13342	one	_
72-27	13343-13345	of	_
72-28	13346-13349	the	_
72-29	13350-13356	target	_
72-30	13357-13364	circles	_
72-31	13365-13368	had	_
72-32	13369-13373	been	_
72-33	13374-13375	.	_

Text=A relatively long stimulus presentation time of two seconds was used to allow subjects to fully encode the target array, minimizing a potential encoding bias on the basis of set size interaction.
73-1	13376-13377	A	_
73-2	13378-13388	relatively	_
73-3	13389-13393	long	_
73-4	13394-13402	stimulus	_
73-5	13403-13415	presentation	_
73-6	13416-13420	time	_
73-7	13421-13423	of	_
73-8	13424-13427	two	_
73-9	13428-13435	seconds	_
73-10	13436-13439	was	_
73-11	13440-13444	used	_
73-12	13445-13447	to	_
73-13	13448-13453	allow	_
73-14	13454-13462	subjects	_
73-15	13463-13465	to	_
73-16	13466-13471	fully	_
73-17	13472-13478	encode	_
73-18	13479-13482	the	_
73-19	13483-13489	target	_
73-20	13490-13495	array	_
73-21	13496-13497	,	_
73-22	13498-13508	minimizing	_
73-23	13509-13510	a	_
73-24	13511-13520	potential	_
73-25	13521-13529	encoding	_
73-26	13530-13534	bias	_
73-27	13535-13537	on	_
73-28	13538-13541	the	_
73-29	13542-13547	basis	_
73-30	13548-13550	of	_
73-31	13551-13554	set	_
73-32	13555-13559	size	_
73-33	13560-13571	interaction	_
73-34	13572-13573	.	_

Text=Likewise, decision or selection requirements were kept constant across set sizes to reduce possible effects of set size on response processes.
74-1	13574-13582	Likewise	_
74-2	13583-13584	,	_
74-3	13585-13593	decision	_
74-4	13594-13596	or	_
74-5	13597-13606	selection	_
74-6	13607-13619	requirements	_
74-7	13620-13624	were	_
74-8	13625-13629	kept	_
74-9	13630-13638	constant	_
74-10	13639-13645	across	_
74-11	13646-13649	set	_
74-12	13650-13655	sizes	_
74-13	13656-13658	to	_
74-14	13659-13665	reduce	_
74-15	13666-13674	possible	_
74-16	13675-13682	effects	_
74-17	13683-13685	of	_
74-18	13686-13689	set	_
74-19	13690-13694	size	_
74-20	13695-13697	on	_
74-21	13698-13706	response	_
74-22	13707-13716	processes	_
74-23	13717-13718	.	_

Text=In addition to load, delay period was manipulated, with delays of 1.5, 3 or 4.5 s. Trial events included a 2-sec target-array presentation, a 1.5, 3 or 4.5 s delay period, and a 3-sec fixed response interval.
75-1	13719-13721	In	_
75-2	13722-13730	addition	_
75-3	13731-13733	to	_
75-4	13734-13738	load	_
75-5	13739-13740	,	_
75-6	13741-13746	delay	_
75-7	13747-13753	period	_
75-8	13754-13757	was	_
75-9	13758-13769	manipulated	_
75-10	13770-13771	,	_
75-11	13772-13776	with	_
75-12	13777-13783	delays	_
75-13	13784-13786	of	_
75-14	13787-13790	1.5	_
75-15	13791-13792	,	_
75-16	13793-13794	3	_
75-17	13795-13797	or	_
75-18	13798-13801	4.5	_
75-19	13802-13804	s.	_
75-20	13805-13810	Trial	_
75-21	13811-13817	events	_
75-22	13818-13826	included	_
75-23	13827-13828	a	_
75-24	13829-13834	2-sec	_
75-25	13835-13847	target-array	_
75-26	13848-13860	presentation	_
75-27	13861-13862	,	_
75-28	13863-13864	a	_
75-29	13865-13868	1.5	_
75-30	13869-13870	,	_
75-31	13871-13872	3	_
75-32	13873-13875	or	_
75-33	13876-13879	4.5	_
75-34	13880-13881	s	_
75-35	13882-13887	delay	_
75-36	13888-13894	period	_
75-37	13895-13896	,	_
75-38	13897-13900	and	_
75-39	13901-13902	a	_
75-40	13903-13908	3-sec	_
75-41	13909-13914	fixed	_
75-42	13915-13923	response	_
75-43	13924-13932	interval	_
75-44	13933-13934	.	_

Text=A central fixation was visible throughout each of the 48 trials (12 per memory set size, with 4 at each delay length for each memory set).
76-1	13935-13936	A	_
76-2	13937-13944	central	_
76-3	13945-13953	fixation	_
76-4	13954-13957	was	_
76-5	13958-13965	visible	_
76-6	13966-13976	throughout	_
76-7	13977-13981	each	_
76-8	13982-13984	of	_
76-9	13985-13988	the	_
76-10	13989-13991	48	_
76-11	13992-13998	trials	_
76-12	13999-14000	(	_
76-13	14001-14003	12	_
76-14	14004-14007	per	_
76-15	14008-14014	memory	_
76-16	14015-14018	set	_
76-17	14019-14023	size	_
76-18	14024-14025	,	_
76-19	14026-14030	with	_
76-20	14031-14032	4	_
76-21	14033-14035	at	_
76-22	14036-14040	each	_
76-23	14041-14046	delay	_
76-24	14047-14053	length	_
76-25	14054-14057	for	_
76-26	14058-14062	each	_
76-27	14063-14069	memory	_
76-28	14070-14073	set	_
76-29	14074-14075	)	_
76-30	14076-14077	.	_

Text=Half the trials were true-positive, and half were true-negative.
77-1	14078-14082	Half	_
77-2	14083-14086	the	_
77-3	14087-14093	trials	_
77-4	14094-14098	were	_
77-5	14099-14112	true-positive	_
77-6	14113-14114	,	_
77-7	14115-14118	and	_
77-8	14119-14123	half	_
77-9	14124-14128	were	_
77-10	14129-14142	true-negative	_
77-11	14143-14144	.	_

Text=Before starting the in-scanner task, subjects underwent a supervised instruction and training period outside of the scanner, and once in the scanner were again reminded of the instructions.
78-1	14145-14151	Before	_
78-2	14152-14160	starting	_
78-3	14161-14164	the	_
78-4	14165-14175	in-scanner	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
78-5	14176-14180	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
78-6	14181-14182	,	_
78-7	14183-14191	subjects	_
78-8	14192-14201	underwent	_
78-9	14202-14203	a	_
78-10	14204-14214	supervised	_
78-11	14215-14226	instruction	_
78-12	14227-14230	and	_
78-13	14231-14239	training	_
78-14	14240-14246	period	_
78-15	14247-14254	outside	_
78-16	14255-14257	of	_
78-17	14258-14261	the	_
78-18	14262-14269	scanner	_
78-19	14270-14271	,	_
78-20	14272-14275	and	_
78-21	14276-14280	once	_
78-22	14281-14283	in	_
78-23	14284-14287	the	_
78-24	14288-14295	scanner	_
78-25	14296-14300	were	_
78-26	14301-14306	again	_
78-27	14307-14315	reminded	_
78-28	14316-14318	of	_
78-29	14319-14322	the	_
78-30	14323-14335	instructions	_
78-31	14336-14337	.	_

Text=Stop signal task In this task, participants were instructed to respond quickly when a ‘ go ’ stimulus was presented on the computer screen, except on the subset of trials where the ‘ go ’ stimulus was paired with a ‘ stop ’ signal.
79-1	14338-14342	Stop	_
79-2	14343-14349	signal	_
79-3	14350-14354	task	_
79-4	14355-14357	In	_
79-5	14358-14362	this	_
79-6	14363-14367	task	_
79-7	14368-14369	,	_
79-8	14370-14382	participants	_
79-9	14383-14387	were	_
79-10	14388-14398	instructed	_
79-11	14399-14401	to	_
79-12	14402-14409	respond	_
79-13	14410-14417	quickly	_
79-14	14418-14422	when	_
79-15	14423-14424	a	_
79-16	14425-14426	‘	_
79-17	14427-14429	go	_
79-18	14430-14431	’	_
79-19	14432-14440	stimulus	_
79-20	14441-14444	was	_
79-21	14445-14454	presented	_
79-22	14455-14457	on	_
79-23	14458-14461	the	_
79-24	14462-14470	computer	_
79-25	14471-14477	screen	_
79-26	14478-14479	,	_
79-27	14480-14486	except	_
79-28	14487-14489	on	_
79-29	14490-14493	the	_
79-30	14494-14500	subset	_
79-31	14501-14503	of	_
79-32	14504-14510	trials	_
79-33	14511-14516	where	_
79-34	14517-14520	the	_
79-35	14521-14522	‘	_
79-36	14523-14525	go	_
79-37	14526-14527	’	_
79-38	14528-14536	stimulus	_
79-39	14537-14540	was	_
79-40	14541-14547	paired	_
79-41	14548-14552	with	_
79-42	14553-14554	a	_
79-43	14555-14556	‘	_
79-44	14557-14561	stop	_
79-45	14562-14563	’	_
79-46	14564-14570	signal	_
79-47	14571-14572	.	_

Text=Specifically, participants were shown a series of go stimuli (left- and right-wards pointing arrows), to which participants were told to respond with left and right button presses, respectively (Go trials).
80-1	14573-14585	Specifically	_
80-2	14586-14587	,	_
80-3	14588-14600	participants	_
80-4	14601-14605	were	_
80-5	14606-14611	shown	_
80-6	14612-14613	a	_
80-7	14614-14620	series	_
80-8	14621-14623	of	_
80-9	14624-14626	go	_
80-10	14627-14634	stimuli	_
80-11	14635-14636	(	_
80-12	14637-14642	left-	_
80-13	14643-14646	and	_
80-14	14647-14658	right-wards	_
80-15	14659-14667	pointing	_
80-16	14668-14674	arrows	_
80-17	14675-14676	)	_
80-18	14677-14678	,	_
80-19	14679-14681	to	_
80-20	14682-14687	which	_
80-21	14688-14700	participants	_
80-22	14701-14705	were	_
80-23	14706-14710	told	_
80-24	14711-14713	to	_
80-25	14714-14721	respond	_
80-26	14722-14726	with	_
80-27	14727-14731	left	_
80-28	14732-14735	and	_
80-29	14736-14741	right	_
80-30	14742-14748	button	_
80-31	14749-14756	presses	_
80-32	14757-14758	,	_
80-33	14759-14771	respectively	_
80-34	14772-14773	(	_
80-35	14774-14776	Go	_
80-36	14777-14783	trials	_
80-37	14784-14785	)	_
80-38	14786-14787	.	_

Text=On a subset of trials (25%), a stop-signal (a 500 Hz tone presented through headphones) was presented a short delay after the go stimulus appeared and lasted for 250 ms (Stop trials).
81-1	14788-14790	On	_
81-2	14791-14792	a	_
81-3	14793-14799	subset	_
81-4	14800-14802	of	_
81-5	14803-14809	trials	_
81-6	14810-14811	(	_
81-7	14812-14814	25	_
81-8	14815-14816	%	_
81-9	14817-14818	)	_
81-10	14819-14820	,	_
81-11	14821-14822	a	_
81-12	14823-14834	stop-signal	_
81-13	14835-14836	(	_
81-14	14837-14838	a	_
81-15	14839-14842	500	_
81-16	14843-14845	Hz	_
81-17	14846-14850	tone	_
81-18	14851-14860	presented	_
81-19	14861-14868	through	_
81-20	14869-14879	headphones	_
81-21	14880-14881	)	_
81-22	14882-14885	was	_
81-23	14886-14895	presented	_
81-24	14896-14897	a	_
81-25	14898-14903	short	_
81-26	14904-14909	delay	_
81-27	14910-14915	after	_
81-28	14916-14919	the	_
81-29	14920-14922	go	_
81-30	14923-14931	stimulus	_
81-31	14932-14940	appeared	_
81-32	14941-14944	and	_
81-33	14945-14951	lasted	_
81-34	14952-14955	for	_
81-35	14956-14959	250	_
81-36	14960-14962	ms	_
81-37	14963-14964	(	_
81-38	14965-14969	Stop	_
81-39	14970-14976	trials	_
81-40	14977-14978	)	_
81-41	14979-14980	.	_

Text=Participants were instructed to respond as quickly and accurately as possible on all trials, but to withhold their response on Stop trials (on trials with the tone).
82-1	14981-14993	Participants	_
82-2	14994-14998	were	_
82-3	14999-15009	instructed	_
82-4	15010-15012	to	_
82-5	15013-15020	respond	_
82-6	15021-15023	as	_
82-7	15024-15031	quickly	_
82-8	15032-15035	and	_
82-9	15036-15046	accurately	_
82-10	15047-15049	as	_
82-11	15050-15058	possible	_
82-12	15059-15061	on	_
82-13	15062-15065	all	_
82-14	15066-15072	trials	_
82-15	15073-15074	,	_
82-16	15075-15078	but	_
82-17	15079-15081	to	_
82-18	15082-15090	withhold	_
82-19	15091-15096	their	_
82-20	15097-15105	response	_
82-21	15106-15108	on	_
82-22	15109-15113	Stop	_
82-23	15114-15120	trials	_
82-24	15121-15122	(	_
82-25	15123-15125	on	_
82-26	15126-15132	trials	_
82-27	15133-15137	with	_
82-28	15138-15141	the	_
82-29	15142-15146	tone	_
82-30	15147-15148	)	_
82-31	15149-15150	.	_

Text=They also were instructed that stopping and going were equally important.
83-1	15151-15155	They	_
83-2	15156-15160	also	_
83-3	15161-15165	were	_
83-4	15166-15176	instructed	_
83-5	15177-15181	that	_
83-6	15182-15190	stopping	_
83-7	15191-15194	and	_
83-8	15195-15200	going	_
83-9	15201-15205	were	_
83-10	15206-15213	equally	_
83-11	15214-15223	important	_
83-12	15224-15225	.	_

Text=On Stop trials, the delay of the onset of the stop-signal, or stop-signal delay (SSD), was varied, such that it was increased after the participant successfully inhibited in response to a stop-signal (making the next stop trial more difficult), and decreased after the participant failed to inhibit in response to a stop-signal (making the next stop trial less difficult).
84-1	15226-15228	On	_
84-2	15229-15233	Stop	_
84-3	15234-15240	trials	_
84-4	15241-15242	,	_
84-5	15243-15246	the	_
84-6	15247-15252	delay	_
84-7	15253-15255	of	_
84-8	15256-15259	the	_
84-9	15260-15265	onset	_
84-10	15266-15268	of	_
84-11	15269-15272	the	_
84-12	15273-15284	stop-signal	_
84-13	15285-15286	,	_
84-14	15287-15289	or	_
84-15	15290-15301	stop-signal	_
84-16	15302-15307	delay	_
84-17	15308-15309	(	_
84-18	15310-15313	SSD	_
84-19	15314-15315	)	_
84-20	15316-15317	,	_
84-21	15318-15321	was	_
84-22	15322-15328	varied	_
84-23	15329-15330	,	_
84-24	15331-15335	such	_
84-25	15336-15340	that	_
84-26	15341-15343	it	_
84-27	15344-15347	was	_
84-28	15348-15357	increased	_
84-29	15358-15363	after	_
84-30	15364-15367	the	_
84-31	15368-15379	participant	_
84-32	15380-15392	successfully	_
84-33	15393-15402	inhibited	_
84-34	15403-15405	in	_
84-35	15406-15414	response	_
84-36	15415-15417	to	_
84-37	15418-15419	a	_
84-38	15420-15431	stop-signal	_
84-39	15432-15433	(	_
84-40	15434-15440	making	_
84-41	15441-15444	the	_
84-42	15445-15449	next	_
84-43	15450-15454	stop	_
84-44	15455-15460	trial	_
84-45	15461-15465	more	_
84-46	15466-15475	difficult	_
84-47	15476-15477	)	_
84-48	15478-15479	,	_
84-49	15480-15483	and	_
84-50	15484-15493	decreased	_
84-51	15494-15499	after	_
84-52	15500-15503	the	_
84-53	15504-15515	participant	_
84-54	15516-15522	failed	_
84-55	15523-15525	to	_
84-56	15526-15533	inhibit	_
84-57	15534-15536	in	_
84-58	15537-15545	response	_
84-59	15546-15548	to	_
84-60	15549-15550	a	_
84-61	15551-15562	stop-signal	_
84-62	15563-15564	(	_
84-63	15565-15571	making	_
84-64	15572-15575	the	_
84-65	15576-15580	next	_
84-66	15581-15585	stop	_
84-67	15586-15591	trial	_
84-68	15592-15596	less	_
84-69	15597-15606	difficult	_
84-70	15607-15608	)	_
84-71	15609-15610	.	_

Text=Each SSD increase or decrease was in 50-ms intervals.
85-1	15611-15615	Each	_
85-2	15616-15619	SSD	_
85-3	15620-15628	increase	_
85-4	15629-15631	or	_
85-5	15632-15640	decrease	_
85-6	15641-15644	was	_
85-7	15645-15647	in	_
85-8	15648-15653	50-ms	_
85-9	15654-15663	intervals	_
85-10	15664-15665	.	_

Text=The SSD values were drawn from two interleaved staircases per block, resulting in 16 trials from each staircase for a total of 32 Stop trials per block.
86-1	15666-15669	The	_
86-2	15670-15673	SSD	_
86-3	15674-15680	values	_
86-4	15681-15685	were	_
86-5	15686-15691	drawn	_
86-6	15692-15696	from	_
86-7	15697-15700	two	_
86-8	15701-15712	interleaved	_
86-9	15713-15723	staircases	_
86-10	15724-15727	per	_
86-11	15728-15733	block	_
86-12	15734-15735	,	_
86-13	15736-15745	resulting	_
86-14	15746-15748	in	_
86-15	15749-15751	16	_
86-16	15752-15758	trials	_
86-17	15759-15763	from	_
86-18	15764-15768	each	_
86-19	15769-15778	staircase	_
86-20	15779-15782	for	_
86-21	15783-15784	a	_
86-22	15785-15790	total	_
86-23	15791-15793	of	_
86-24	15794-15796	32	_
86-25	15797-15801	Stop	_
86-26	15802-15808	trials	_
86-27	15809-15812	per	_
86-28	15813-15818	block	_
86-29	15819-15820	.	_

Text=On the testing day, participants completed two experimental runs (one run outside of the scanner and one while inside of the scanner).
87-1	15821-15823	On	_
87-2	15824-15827	the	_
87-3	15828-15835	testing	_
87-4	15836-15839	day	_
87-5	15840-15841	,	_
87-6	15842-15854	participants	_
87-7	15855-15864	completed	_
87-8	15865-15868	two	_
87-9	15869-15881	experimental	_
87-10	15882-15886	runs	_
87-11	15887-15888	(	_
87-12	15889-15892	one	_
87-13	15893-15896	run	_
87-14	15897-15904	outside	_
87-15	15905-15907	of	_
87-16	15908-15911	the	_
87-17	15912-15919	scanner	_
87-18	15920-15923	and	_
87-19	15924-15927	one	_
87-20	15928-15933	while	_
87-21	15934-15940	inside	_
87-22	15941-15943	of	_
87-23	15944-15947	the	_
87-24	15948-15955	scanner	_
87-25	15956-15957	)	_
87-26	15958-15959	.	_

Text=In the first task run completed outside of the scanner, SSD values started at 250 and 350 ms for staircase 1 and 2, respectively.
88-1	15960-15962	In	_
88-2	15963-15966	the	_
88-3	15967-15972	first	_
88-4	15973-15977	task	_
88-5	15978-15981	run	_
88-6	15982-15991	completed	_
88-7	15992-15999	outside	_
88-8	16000-16002	of	_
88-9	16003-16006	the	_
88-10	16007-16014	scanner	_
88-11	16015-16016	,	_
88-12	16017-16020	SSD	_
88-13	16021-16027	values	_
88-14	16028-16035	started	_
88-15	16036-16038	at	_
88-16	16039-16042	250	_
88-17	16043-16046	and	_
88-18	16047-16050	350	_
88-19	16051-16053	ms	_
88-20	16054-16057	for	_
88-21	16058-16067	staircase	_
88-22	16068-16069	1	_
88-23	16070-16073	and	_
88-24	16074-16075	2	_
88-25	16076-16077	,	_
88-26	16078-16090	respectively	_
88-27	16091-16092	.	_

Text=At the end of the behavioral run, the last SSD time from each staircase was then carried over to be the initial SSD for the scan run.
89-1	16093-16095	At	_
89-2	16096-16099	the	_
89-3	16100-16103	end	_
89-4	16104-16106	of	_
89-5	16107-16110	the	_
89-6	16111-16121	behavioral	_
89-7	16122-16125	run	_
89-8	16126-16127	,	_
89-9	16128-16131	the	_
89-10	16132-16136	last	_
89-11	16137-16140	SSD	_
89-12	16141-16145	time	_
89-13	16146-16150	from	_
89-14	16151-16155	each	_
89-15	16156-16165	staircase	_
89-16	16166-16169	was	_
89-17	16170-16174	then	_
89-18	16175-16182	carried	_
89-19	16183-16187	over	_
89-20	16188-16190	to	_
89-21	16191-16193	be	_
89-22	16194-16197	the	_
89-23	16198-16205	initial	_
89-24	16206-16209	SSD	_
89-25	16210-16213	for	_
89-26	16214-16217	the	_
89-27	16218-16222	scan	_
89-28	16223-16226	run	_
89-29	16227-16228	.	_

Text=This one-up/one-down tracking procedure ensured that subjects successfully inhibited on approximately 50% of inhibition trials.
90-1	16229-16233	This	_
90-2	16234-16249	one-up/one-down	_
90-3	16250-16258	tracking	_
90-4	16259-16268	procedure	_
90-5	16269-16276	ensured	_
90-6	16277-16281	that	_
90-7	16282-16290	subjects	_
90-8	16291-16303	successfully	_
90-9	16304-16313	inhibited	_
90-10	16314-16316	on	_
90-11	16317-16330	approximately	_
90-12	16331-16333	50	_
90-13	16334-16335	%	_
90-14	16336-16338	of	_
90-15	16339-16349	inhibition	_
90-16	16350-16356	trials	_
90-17	16357-16358	.	_

Text=Also as a result, difficulty level is individualized across subjects and both behavioral performance and numbers of successful stop trials are equated across subjects.
91-1	16359-16363	Also	_
91-2	16364-16366	as	_
91-3	16367-16368	a	_
91-4	16369-16375	result	_
91-5	16376-16377	,	_
91-6	16378-16388	difficulty	_
91-7	16389-16394	level	_
91-8	16395-16397	is	_
91-9	16398-16412	individualized	_
91-10	16413-16419	across	_
91-11	16420-16428	subjects	_
91-12	16429-16432	and	_
91-13	16433-16437	both	_
91-14	16438-16448	behavioral	_
91-15	16449-16460	performance	_
91-16	16461-16464	and	_
91-17	16465-16472	numbers	_
91-18	16473-16475	of	_
91-19	16476-16486	successful	_
91-20	16487-16491	stop	_
91-21	16492-16498	trials	_
91-22	16499-16502	are	_
91-23	16503-16510	equated	_
91-24	16511-16517	across	_
91-25	16518-16526	subjects	_
91-26	16527-16528	.	_

Text=Each experiment run contained 128 trials, 96 of which were Go trials and 32 of which were Stop trials, each presented randomly.
92-1	16529-16533	Each	_
92-2	16534-16544	experiment	_
92-3	16545-16548	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-4	16549-16558	contained	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-5	16559-16562	128	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-6	16563-16569	trials	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-7	16570-16571	,	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-8	16572-16574	96	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-9	16575-16577	of	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-10	16578-16583	which	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-11	16584-16588	were	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-12	16589-16591	Go	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
92-13	16592-16598	trials	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
92-14	16599-16602	and	_
92-15	16603-16605	32	_
92-16	16606-16608	of	_
92-17	16609-16614	which	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
92-18	16615-16619	were	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
92-19	16620-16624	Stop	_
92-20	16625-16631	trials	http://maven.renci.org/NeuroBridge/neurobridge#Unmedicated
92-21	16632-16633	,	_
92-22	16634-16638	each	_
92-23	16639-16648	presented	_
92-24	16649-16657	randomly	_
92-25	16658-16659	.	_

Text=All trials were preceded by a 500 ms fixation cross in the center of the screen, then each trial began with the appearance of an arrow and ended after 1000 ms, followed by the null period.
93-1	16660-16663	All	_
93-2	16664-16670	trials	_
93-3	16671-16675	were	_
93-4	16676-16684	preceded	_
93-5	16685-16687	by	_
93-6	16688-16689	a	_
93-7	16690-16693	500	_
93-8	16694-16696	ms	_
93-9	16697-16705	fixation	_
93-10	16706-16711	cross	_
93-11	16712-16714	in	_
93-12	16715-16718	the	_
93-13	16719-16725	center	_
93-14	16726-16728	of	_
93-15	16729-16732	the	_
93-16	16733-16739	screen	_
93-17	16740-16741	,	_
93-18	16742-16746	then	_
93-19	16747-16751	each	_
93-20	16752-16757	trial	_
93-21	16758-16763	began	_
93-22	16764-16768	with	_
93-23	16769-16772	the	_
93-24	16773-16783	appearance	_
93-25	16784-16786	of	_
93-26	16787-16789	an	_
93-27	16790-16795	arrow	_
93-28	16796-16799	and	_
93-29	16800-16805	ended	_
93-30	16806-16811	after	_
93-31	16812-16816	1000	_
93-32	16817-16819	ms	_
93-33	16820-16821	,	_
93-34	16822-16830	followed	_
93-35	16831-16833	by	_
93-36	16834-16837	the	_
93-37	16838-16842	null	_
93-38	16843-16849	period	_
93-39	16850-16851	.	_

Text=Jittered null events separated every trial (with a blank screen), with the duration of null events sampled from an exponential distribution (null events ranged from 0.5 to 4 s, with a mean of 1 s).
94-1	16852-16860	Jittered	_
94-2	16861-16865	null	_
94-3	16866-16872	events	_
94-4	16873-16882	separated	_
94-5	16883-16888	every	_
94-6	16889-16894	trial	_
94-7	16895-16896	(	_
94-8	16897-16901	with	_
94-9	16902-16903	a	_
94-10	16904-16909	blank	_
94-11	16910-16916	screen	_
94-12	16917-16918	)	_
94-13	16919-16920	,	_
94-14	16921-16925	with	_
94-15	16926-16929	the	_
94-16	16930-16938	duration	_
94-17	16939-16941	of	_
94-18	16942-16946	null	_
94-19	16947-16953	events	_
94-20	16954-16961	sampled	_
94-21	16962-16966	from	_
94-22	16967-16969	an	_
94-23	16970-16981	exponential	_
94-24	16982-16994	distribution	_
94-25	16995-16996	(	_
94-26	16997-17001	null	_
94-27	17002-17008	events	_
94-28	17009-17015	ranged	_
94-29	17016-17020	from	_
94-30	17021-17024	0.5	_
94-31	17025-17027	to	_
94-32	17028-17029	4	_
94-33	17030-17031	s	_
94-34	17032-17033	,	_
94-35	17034-17038	with	_
94-36	17039-17040	a	_
94-37	17041-17045	mean	_
94-38	17046-17048	of	_
94-39	17049-17050	1	_
94-40	17051-17052	s	_
94-41	17053-17054	)	_
94-42	17055-17056	.	_

Text=Task-switching task In this task, participants were presented with a series of one of four possible stimuli and asked to respond to the stimulus based on the task cue presented prior to, and above, the image.
95-1	17057-17071	Task-switching	_
95-2	17072-17076	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
95-3	17077-17079	In	_
95-4	17080-17084	this	_
95-5	17085-17089	task	_
95-6	17090-17091	,	_
95-7	17092-17104	participants	_
95-8	17105-17109	were	_
95-9	17110-17119	presented	_
95-10	17120-17124	with	_
95-11	17125-17126	a	_
95-12	17127-17133	series	_
95-13	17134-17136	of	_
95-14	17137-17140	one	_
95-15	17141-17143	of	_
95-16	17144-17148	four	_
95-17	17149-17157	possible	_
95-18	17158-17165	stimuli	_
95-19	17166-17169	and	_
95-20	17170-17175	asked	_
95-21	17176-17178	to	_
95-22	17179-17186	respond	_
95-23	17187-17189	to	_
95-24	17190-17193	the	_
95-25	17194-17202	stimulus	_
95-26	17203-17208	based	_
95-27	17209-17211	on	_
95-28	17212-17215	the	_
95-29	17216-17220	task	_
95-30	17221-17224	cue	_
95-31	17225-17234	presented	_
95-32	17235-17240	prior	_
95-33	17241-17243	to	_
95-34	17244-17245	,	_
95-35	17246-17249	and	_
95-36	17250-17255	above	_
95-37	17256-17257	,	_
95-38	17258-17261	the	_
95-39	17262-17267	image	_
95-40	17268-17269	.	_

Text=The four stimuli included a red triangle, red circle, green triangle, and green circle.
96-1	17270-17273	The	_
96-2	17274-17278	four	_
96-3	17279-17286	stimuli	_
96-4	17287-17295	included	_
96-5	17296-17297	a	_
96-6	17298-17301	red	_
96-7	17302-17310	triangle	_
96-8	17311-17312	,	_
96-9	17313-17316	red	_
96-10	17317-17323	circle	_
96-11	17324-17325	,	_
96-12	17326-17331	green	_
96-13	17332-17340	triangle	_
96-14	17341-17342	,	_
96-15	17343-17346	and	_
96-16	17347-17352	green	_
96-17	17353-17359	circle	_
96-18	17360-17361	.	_

Text=Participants switched between responding to the image ’ s color (i.e., red or green) or the shape (i.e., triangle or circle).
97-1	17362-17374	Participants	_
97-2	17375-17383	switched	_
97-3	17384-17391	between	_
97-4	17392-17402	responding	_
97-5	17403-17405	to	_
97-6	17406-17409	the	_
97-7	17410-17415	image	_
97-8	17416-17417	’	_
97-9	17418-17419	s	_
97-10	17420-17425	color	_
97-11	17426-17427	(	_
97-12	17428-17432	i.e.	_
97-13	17433-17434	,	_
97-14	17435-17438	red	_
97-15	17439-17441	or	_
97-16	17442-17447	green	_
97-17	17448-17449	)	_
97-18	17450-17452	or	_
97-19	17453-17456	the	_
97-20	17457-17462	shape	_
97-21	17463-17464	(	_
97-22	17465-17469	i.e.	_
97-23	17470-17471	,	_
97-24	17472-17480	triangle	_
97-25	17481-17483	or	_
97-26	17484-17490	circle	_
97-27	17491-17492	)	_
97-28	17493-17494	.	_

Text=Cues presented included either ‘ SHAPE ’ or ‘ S ’ on trials where participants were expected to respond to the shape of the stimulus; cues presented included either ‘ COLOR ’ or ‘ C ’ on trials where participants were expected to respond to the color of the stimulus.
98-1	17495-17499	Cues	_
98-2	17500-17509	presented	_
98-3	17510-17518	included	_
98-4	17519-17525	either	_
98-5	17526-17527	‘	_
98-6	17528-17533	SHAPE	_
98-7	17534-17535	’	_
98-8	17536-17538	or	_
98-9	17539-17540	‘	_
98-10	17541-17542	S	_
98-11	17543-17544	’	_
98-12	17545-17547	on	_
98-13	17548-17554	trials	_
98-14	17555-17560	where	_
98-15	17561-17573	participants	_
98-16	17574-17578	were	_
98-17	17579-17587	expected	_
98-18	17588-17590	to	_
98-19	17591-17598	respond	_
98-20	17599-17601	to	_
98-21	17602-17605	the	_
98-22	17606-17611	shape	_
98-23	17612-17614	of	_
98-24	17615-17618	the	_
98-25	17619-17627	stimulus	_
98-26	17628-17629	;	_
98-27	17630-17634	cues	_
98-28	17635-17644	presented	_
98-29	17645-17653	included	_
98-30	17654-17660	either	_
98-31	17661-17662	‘	_
98-32	17663-17668	COLOR	_
98-33	17669-17670	’	_
98-34	17671-17673	or	_
98-35	17674-17675	‘	_
98-36	17676-17677	C	_
98-37	17678-17679	’	_
98-38	17680-17682	on	_
98-39	17683-17689	trials	_
98-40	17690-17695	where	_
98-41	17696-17708	participants	_
98-42	17709-17713	were	_
98-43	17714-17722	expected	_
98-44	17723-17725	to	_
98-45	17726-17733	respond	_
98-46	17734-17736	to	_
98-47	17737-17740	the	_
98-48	17741-17746	color	_
98-49	17747-17749	of	_
98-50	17750-17753	the	_
98-51	17754-17762	stimulus	_
98-52	17763-17764	.	_

Text=On 33% of trials the instructions switched, such that participants were instructed to switch from responding from shape to color, or vice versa.
99-1	17765-17767	On	_
99-2	17768-17770	33	_
99-3	17771-17772	%	_
99-4	17773-17775	of	_
99-5	17776-17782	trials	_
99-6	17783-17786	the	_
99-7	17787-17799	instructions	_
99-8	17800-17808	switched	_
99-9	17809-17810	,	_
99-10	17811-17815	such	_
99-11	17816-17820	that	_
99-12	17821-17833	participants	_
99-13	17834-17838	were	_
99-14	17839-17849	instructed	_
99-15	17850-17852	to	_
99-16	17853-17859	switch	_
99-17	17860-17864	from	_
99-18	17865-17875	responding	_
99-19	17876-17880	from	_
99-20	17881-17886	shape	_
99-21	17887-17889	to	_
99-22	17890-17895	color	_
99-23	17896-17897	,	_
99-24	17898-17900	or	_
99-25	17901-17905	vice	_
99-26	17906-17911	versa	_
99-27	17912-17913	.	_

Text=On 67% of trials, the instructions remained the same but the cues changed.
100-1	17914-17916	On	_
100-2	17917-17919	67	_
100-3	17920-17921	%	_
100-4	17922-17924	of	_
100-5	17925-17931	trials	_
100-6	17932-17933	,	_
100-7	17934-17937	the	_
100-8	17938-17950	instructions	_
100-9	17951-17959	remained	_
100-10	17960-17963	the	_
100-11	17964-17968	same	_
100-12	17969-17972	but	_
100-13	17973-17976	the	_
100-14	17977-17981	cues	_
100-15	17982-17989	changed	_
100-16	17990-17991	.	_

Text=This task is designed to measure the changes in reaction time between trials requiring versus not requiring a switch in responding.
101-1	17992-17996	This	_
101-2	17997-18001	task	_
101-3	18002-18004	is	_
101-4	18005-18013	designed	_
101-5	18014-18016	to	_
101-6	18017-18024	measure	_
101-7	18025-18028	the	_
101-8	18029-18036	changes	_
101-9	18037-18039	in	_
101-10	18040-18048	reaction	_
101-11	18049-18053	time	_
101-12	18054-18061	between	_
101-13	18062-18068	trials	_
101-14	18069-18078	requiring	_
101-15	18079-18085	versus	_
101-16	18086-18089	not	_
101-17	18090-18099	requiring	_
101-18	18100-18101	a	_
101-19	18102-18108	switch	_
101-20	18109-18111	in	_
101-21	18112-18122	responding	_
101-22	18123-18124	.	_

Text=Participants completed a total of 96 trials, for a total run time of 6 min 52 s. Breath holding task In this task, participants were asked to alternate between holding their breath and breathing regularly while resting.
102-1	18125-18137	Participants	_
102-2	18138-18147	completed	_
102-3	18148-18149	a	_
102-4	18150-18155	total	_
102-5	18156-18158	of	_
102-6	18159-18161	96	_
102-7	18162-18168	trials	_
102-8	18169-18170	,	_
102-9	18171-18174	for	_
102-10	18175-18176	a	_
102-11	18177-18182	total	_
102-12	18183-18186	run	_
102-13	18187-18191	time	_
102-14	18192-18194	of	_
102-15	18195-18196	6	_
102-16	18197-18200	min	_
102-17	18201-18203	52	_
102-18	18204-18206	s.	_
102-19	18207-18213	Breath	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
102-20	18214-18221	holding	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
102-21	18222-18226	task	http://maven.renci.org/NeuroBridge/neurobridge#BreathHoldTask
102-22	18227-18229	In	_
102-23	18230-18234	this	_
102-24	18235-18239	task	_
102-25	18240-18241	,	_
102-26	18242-18254	participants	_
102-27	18255-18259	were	_
102-28	18260-18265	asked	_
102-29	18266-18268	to	_
102-30	18269-18278	alternate	_
102-31	18279-18286	between	_
102-32	18287-18294	holding	_
102-33	18295-18300	their	_
102-34	18301-18307	breath	_
102-35	18308-18311	and	_
102-36	18312-18321	breathing	_
102-37	18322-18331	regularly	_
102-38	18332-18337	while	_
102-39	18338-18345	resting	_
102-40	18346-18347	.	_

Text=Participants were presented with bars on the screen in order to pace breath holding.
103-1	18348-18360	Participants	_
103-2	18361-18365	were	_
103-3	18366-18375	presented	_
103-4	18376-18380	with	_
103-5	18381-18385	bars	_
103-6	18386-18388	on	_
103-7	18389-18392	the	_
103-8	18393-18399	screen	_
103-9	18400-18402	in	_
103-10	18403-18408	order	_
103-11	18409-18411	to	_
103-12	18412-18416	pace	_
103-13	18417-18423	breath	_
103-14	18424-18431	holding	_
103-15	18432-18433	.	_

Text=When the bar was green (lasting 13.5 s), they were asked to breathe regularly; when the bar was yellow (lasting 3 s), they were asked to prepare to hold their breath; and when the bar was red, they were asked to hold their breath for 13.5 s. This cycle was repeated five times, for a total run time of 2 min and 46 s. Participants performed the BHT in the scanner while wearing a respiratory belt in order to measure breathing.
104-1	18434-18438	When	_
104-2	18439-18442	the	_
104-3	18443-18446	bar	_
104-4	18447-18450	was	_
104-5	18451-18456	green	_
104-6	18457-18458	(	_
104-7	18459-18466	lasting	_
104-8	18467-18471	13.5	_
104-9	18472-18473	s	_
104-10	18474-18475	)	_
104-11	18476-18477	,	_
104-12	18478-18482	they	_
104-13	18483-18487	were	_
104-14	18488-18493	asked	_
104-15	18494-18496	to	_
104-16	18497-18504	breathe	_
104-17	18505-18514	regularly	_
104-18	18515-18516	;	_
104-19	18517-18521	when	_
104-20	18522-18525	the	_
104-21	18526-18529	bar	_
104-22	18530-18533	was	_
104-23	18534-18540	yellow	_
104-24	18541-18542	(	_
104-25	18543-18550	lasting	_
104-26	18551-18552	3	_
104-27	18553-18554	s	_
104-28	18555-18556	)	_
104-29	18557-18558	,	_
104-30	18559-18563	they	_
104-31	18564-18568	were	_
104-32	18569-18574	asked	_
104-33	18575-18577	to	_
104-34	18578-18585	prepare	_
104-35	18586-18588	to	_
104-36	18589-18593	hold	_
104-37	18594-18599	their	_
104-38	18600-18606	breath	_
104-39	18607-18608	;	_
104-40	18609-18612	and	_
104-41	18613-18617	when	_
104-42	18618-18621	the	_
104-43	18622-18625	bar	_
104-44	18626-18629	was	_
104-45	18630-18633	red	_
104-46	18634-18635	,	_
104-47	18636-18640	they	_
104-48	18641-18645	were	_
104-49	18646-18651	asked	_
104-50	18652-18654	to	_
104-51	18655-18659	hold	_
104-52	18660-18665	their	_
104-53	18666-18672	breath	_
104-54	18673-18676	for	_
104-55	18677-18681	13.5	_
104-56	18682-18684	s.	_
104-57	18685-18689	This	_
104-58	18690-18695	cycle	_
104-59	18696-18699	was	_
104-60	18700-18708	repeated	_
104-61	18709-18713	five	_
104-62	18714-18719	times	_
104-63	18720-18721	,	_
104-64	18722-18725	for	_
104-65	18726-18727	a	_
104-66	18728-18733	total	_
104-67	18734-18737	run	_
104-68	18738-18742	time	_
104-69	18743-18745	of	_
104-70	18746-18747	2	_
104-71	18748-18751	min	_
104-72	18752-18755	and	_
104-73	18756-18758	46	_
104-74	18759-18761	s.	_
104-75	18762-18774	Participants	_
104-76	18775-18784	performed	_
104-77	18785-18788	the	_
104-78	18789-18792	BHT	http://maven.renci.org/NeuroBridge/neurobridge#Thing
104-79	18793-18795	in	_
104-80	18796-18799	the	_
104-81	18800-18807	scanner	_
104-82	18808-18813	while	_
104-83	18814-18821	wearing	_
104-84	18822-18823	a	_
104-85	18824-18835	respiratory	_
104-86	18836-18840	belt	_
104-87	18841-18843	in	_
104-88	18844-18849	order	_
104-89	18850-18852	to	_
104-90	18853-18860	measure	_
104-91	18861-18870	breathing	_
104-92	18871-18872	.	_

Text=The purpose of this task was to assess the contribution of respiratory rhythms to changes in the BOLD signal.
105-1	18873-18876	The	_
105-2	18877-18884	purpose	_
105-3	18885-18887	of	_
105-4	18888-18892	this	_
105-5	18893-18897	task	_
105-6	18898-18901	was	_
105-7	18902-18904	to	_
105-8	18905-18911	assess	_
105-9	18912-18915	the	_
105-10	18916-18928	contribution	_
105-11	18929-18931	of	_
105-12	18932-18943	respiratory	_
105-13	18944-18951	rhythms	_
105-14	18952-18954	to	_
105-15	18955-18962	changes	_
105-16	18963-18965	in	_
105-17	18966-18969	the	_
105-18	18970-18974	BOLD	_
105-19	18975-18981	signal	_
105-20	18982-18983	.	_

Text=Physiological recording During the breath holding and resting fMRI scans, physiological data were collected using a BIOPAC MP150 with Pulse Oximeter and Respiration modules.
106-1	18984-18997	Physiological	_
106-2	18998-19007	recording	_
106-3	19008-19014	During	_
106-4	19015-19018	the	_
106-5	19019-19025	breath	_
106-6	19026-19033	holding	_
106-7	19034-19037	and	_
106-8	19038-19045	resting	_
106-9	19046-19050	fMRI	_
106-10	19051-19056	scans	_
106-11	19057-19058	,	_
106-12	19059-19072	physiological	_
106-13	19073-19077	data	_
106-14	19078-19082	were	_
106-15	19083-19092	collected	_
106-16	19093-19098	using	_
106-17	19099-19100	a	_
106-18	19101-19107	BIOPAC	_
106-19	19108-19113	MP150	_
106-20	19114-19118	with	_
106-21	19119-19124	Pulse	_
106-22	19125-19133	Oximeter	_
106-23	19134-19137	and	_
106-24	19138-19149	Respiration	_
106-25	19150-19157	modules	_
106-26	19158-19159	.	_

Text=Data were sampled at 1000 Hz and recorded using BIOPAC Acknowledge software.
107-1	19160-19164	Data	_
107-2	19165-19169	were	_
107-3	19170-19177	sampled	_
107-4	19178-19180	at	_
107-5	19181-19185	1000	_
107-6	19186-19188	Hz	_
107-7	19189-19192	and	_
107-8	19193-19201	recorded	_
107-9	19202-19207	using	_
107-10	19208-19214	BIOPAC	_
107-11	19215-19226	Acknowledge	_
107-12	19227-19235	software	_
107-13	19236-19237	.	_

Text=Data Records The data set is hosted on OpenfMRI under the accession number ds000030 (Data Citation 1).
108-1	19238-19242	Data	_
108-2	19243-19250	Records	_
108-3	19251-19254	The	_
108-4	19255-19259	data	_
108-5	19260-19263	set	_
108-6	19264-19266	is	_
108-7	19267-19273	hosted	_
108-8	19274-19276	on	_
108-9	19277-19285	OpenfMRI	_
108-10	19286-19291	under	_
108-11	19292-19295	the	_
108-12	19296-19305	accession	_
108-13	19306-19312	number	_
108-14	19313-19321	ds000030	_
108-15	19322-19323	(	_
108-16	19324-19328	Data	_
108-17	19329-19337	Citation	_
108-18	19338-19339	1	_
108-19	19340-19341	)	_
108-20	19342-19343	.	_

Text=The files are organized in the Brain Imaging Data Structure (BIDS) version 1.0.0rc3 format, and provided in multiple gzip-compressed tar archives.
109-1	19344-19347	The	_
109-2	19348-19353	files	_
109-3	19354-19357	are	_
109-4	19358-19367	organized	_
109-5	19368-19370	in	_
109-6	19371-19374	the	_
109-7	19375-19380	Brain	_
109-8	19381-19388	Imaging	_
109-9	19389-19393	Data	_
109-10	19394-19403	Structure	_
109-11	19404-19405	(	_
109-12	19406-19410	BIDS	_
109-13	19411-19412	)	_
109-14	19413-19420	version	_
109-15	19421-19429	1.0.0rc3	_
109-16	19430-19436	format	_
109-17	19437-19438	,	_
109-18	19439-19442	and	_
109-19	19443-19451	provided	_
109-20	19452-19454	in	_
109-21	19455-19463	multiple	_
109-22	19464-19479	gzip-compressed	_
109-23	19480-19483	tar	_
109-24	19484-19492	archives	_
109-25	19493-19494	.	_

Text=BIDS provides a consistent naming convention and folder structure that is amenable to automated processing.
110-1	19495-19499	BIDS	_
110-2	19500-19508	provides	_
110-3	19509-19510	a	_
110-4	19511-19521	consistent	_
110-5	19522-19528	naming	_
110-6	19529-19539	convention	_
110-7	19540-19543	and	_
110-8	19544-19550	folder	_
110-9	19551-19560	structure	_
110-10	19561-19565	that	_
110-11	19566-19568	is	_
110-12	19569-19577	amenable	_
110-13	19578-19580	to	_
110-14	19581-19590	automated	_
110-15	19591-19601	processing	_
110-16	19602-19603	.	_

Text=At the top-level, machine-readable text files in javascript object notation (JSON) are provided describing each fMRI task.
111-1	19604-19606	At	_
111-2	19607-19610	the	_
111-3	19611-19620	top-level	_
111-4	19621-19622	,	_
111-5	19623-19639	machine-readable	_
111-6	19640-19644	text	_
111-7	19645-19650	files	_
111-8	19651-19653	in	_
111-9	19654-19664	javascript	_
111-10	19665-19671	object	_
111-11	19672-19680	notation	_
111-12	19681-19682	(	_
111-13	19683-19687	JSON	_
111-14	19688-19689	)	_
111-15	19690-19693	are	_
111-16	19694-19702	provided	_
111-17	19703-19713	describing	_
111-18	19714-19718	each	_
111-19	19719-19723	fMRI	_
111-20	19724-19728	task	_
111-21	19729-19730	.	_

Text=A demographics file (participants.tsv; tab-delimited format) contains the unique participant number, age group, diagnosis, and an indication of which scan data are present for each subject.
112-1	19731-19732	A	_
112-2	19733-19745	demographics	_
112-3	19746-19750	file	_
112-4	19751-19752	(	_
112-5	19753-19769	participants.tsv	_
112-6	19770-19771	;	_
112-7	19772-19785	tab-delimited	_
112-8	19786-19792	format	_
112-9	19793-19794	)	_
112-10	19795-19803	contains	_
112-11	19804-19807	the	_
112-12	19808-19814	unique	_
112-13	19815-19826	participant	_
112-14	19827-19833	number	_
112-15	19834-19835	,	_
112-16	19836-19839	age	_
112-17	19840-19845	group	_
112-18	19846-19847	,	_
112-19	19848-19857	diagnosis	_
112-20	19858-19859	,	_
112-21	19860-19863	and	_
112-22	19864-19866	an	_
112-23	19867-19877	indication	_
112-24	19878-19880	of	_
112-25	19881-19886	which	_
112-26	19887-19891	scan	_
112-27	19892-19896	data	_
112-28	19897-19900	are	_
112-29	19901-19908	present	_
112-30	19909-19912	for	_
112-31	19913-19917	each	_
112-32	19918-19925	subject	_
112-33	19926-19927	.	_

Text=func: BOLD contrast fMRI image data (both task-based and resting state), fMRI task event files, physiological monitoring logs; anat: high resolution T1-weighted image data used for structural analysis, cortical parcellation, and co-registration to standard templates; dwi: Diffusion-weighted image data used for experimental white matter characterization methods such as Diffusion Tensor Imaging; beh: Stop Signal task training run collected outside of the MRI scanner.
113-1	19928-19932	func	_
113-2	19933-19934	:	_
113-3	19935-19939	BOLD	_
113-4	19940-19948	contrast	_
113-5	19949-19953	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
113-6	19954-19959	image	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
113-7	19960-19964	data	_
113-8	19965-19966	(	_
113-9	19967-19971	both	_
113-10	19972-19982	task-based	_
113-11	19983-19986	and	_
113-12	19987-19994	resting	_
113-13	19995-20000	state	_
113-14	20001-20002	)	_
113-15	20003-20004	,	_
113-16	20005-20009	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
113-17	20010-20014	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
113-18	20015-20020	event	_
113-19	20021-20026	files	_
113-20	20027-20028	,	_
113-21	20029-20042	physiological	_
113-22	20043-20053	monitoring	_
113-23	20054-20058	logs	_
113-24	20059-20060	;	_
113-25	20061-20065	anat	_
113-26	20066-20067	:	_
113-27	20068-20072	high	_
113-28	20073-20083	resolution	_
113-29	20084-20095	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
113-30	20096-20101	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
113-31	20102-20106	data	_
113-32	20107-20111	used	_
113-33	20112-20115	for	_
113-34	20116-20126	structural	_
113-35	20127-20135	analysis	_
113-36	20136-20137	,	_
113-37	20138-20146	cortical	_
113-38	20147-20159	parcellation	_
113-39	20160-20161	,	_
113-40	20162-20165	and	_
113-41	20166-20181	co-registration	_
113-42	20182-20184	to	_
113-43	20185-20193	standard	_
113-44	20194-20203	templates	_
113-45	20204-20205	;	_
113-46	20206-20209	dwi	_
113-47	20210-20211	:	_
113-48	20212-20230	Diffusion-weighted	_
113-49	20231-20236	image	_
113-50	20237-20241	data	_
113-51	20242-20246	used	_
113-52	20247-20250	for	_
113-53	20251-20263	experimental	_
113-54	20264-20269	white	_
113-55	20270-20276	matter	_
113-56	20277-20293	characterization	_
113-57	20294-20301	methods	_
113-58	20302-20306	such	_
113-59	20307-20309	as	_
113-60	20310-20319	Diffusion	_
113-61	20320-20326	Tensor	_
113-62	20327-20334	Imaging	_
113-63	20335-20336	;	_
113-64	20337-20340	beh	_
113-65	20341-20342	:	_
113-66	20343-20347	Stop	_
113-67	20348-20354	Signal	_
113-68	20355-20359	task	_
113-69	20360-20368	training	_
113-70	20369-20372	run	_
113-71	20373-20382	collected	_
113-72	20383-20390	outside	_
113-73	20391-20393	of	_
113-74	20394-20397	the	_
113-75	20398-20401	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
113-76	20402-20409	scanner	_
113-77	20410-20411	.	_

Text=The neuroimaging data collected for each participant are organized in a sub- <subject_id> data folder.
114-1	20412-20415	The	_
114-2	20416-20428	neuroimaging	_
114-3	20429-20433	data	_
114-4	20434-20443	collected	_
114-5	20444-20447	for	_
114-6	20448-20452	each	_
114-7	20453-20464	participant	_
114-8	20465-20468	are	_
114-9	20469-20478	organized	_
114-10	20479-20481	in	_
114-11	20482-20483	a	_
114-12	20484-20488	sub-	_
114-13	20489-20490	<	_
114-14	20491-20501	subject_id	_
114-15	20502-20503	>	_
114-16	20504-20508	data	_
114-17	20509-20515	folder	_
114-18	20516-20517	.	_

Text=Each of these folders contain the following data files that collectively represent a participant ’ s study visit: bart: Balloon analog risk task stopsignal: Stop signal task pamenc: Paired memory encoding task pamret: Paired memory retrieval task scap: Spatial working memory task taskswitch: Task switching task bht: Breath-holding task rest: Resting state (eyes open) The label <taskname> refers to data from one of the tasks performed during the visit: An additional directory named ‘ phenotype ’ contains additional phenotypic information (such as neuropsychological testing results); for each measurement, there is a tab-delimited text file along with a JSON file containing the data dictionary and measurement-level metadata.
115-1	20518-20522	Each	_
115-2	20523-20525	of	_
115-3	20526-20531	these	_
115-4	20532-20539	folders	_
115-5	20540-20547	contain	_
115-6	20548-20551	the	_
115-7	20552-20561	following	_
115-8	20562-20566	data	_
115-9	20567-20572	files	_
115-10	20573-20577	that	_
115-11	20578-20590	collectively	_
115-12	20591-20600	represent	_
115-13	20601-20602	a	_
115-14	20603-20614	participant	_
115-15	20615-20616	’	_
115-16	20617-20618	s	_
115-17	20619-20624	study	_
115-18	20625-20630	visit	_
115-19	20631-20632	:	_
115-20	20633-20637	bart	_
115-21	20638-20639	:	_
115-22	20640-20647	Balloon	_
115-23	20648-20654	analog	_
115-24	20655-20659	risk	_
115-25	20660-20664	task	_
115-26	20665-20675	stopsignal	_
115-27	20676-20677	:	_
115-28	20678-20682	Stop	_
115-29	20683-20689	signal	_
115-30	20690-20694	task	_
115-31	20695-20701	pamenc	_
115-32	20702-20703	:	_
115-33	20704-20710	Paired	_
115-34	20711-20717	memory	_
115-35	20718-20726	encoding	_
115-36	20727-20731	task	_
115-37	20732-20738	pamret	_
115-38	20739-20740	:	_
115-39	20741-20747	Paired	_
115-40	20748-20754	memory	_
115-41	20755-20764	retrieval	_
115-42	20765-20769	task	_
115-43	20770-20774	scap	_
115-44	20775-20776	:	_
115-45	20777-20784	Spatial	_
115-46	20785-20792	working	_
115-47	20793-20799	memory	_
115-48	20800-20804	task	_
115-49	20805-20815	taskswitch	_
115-50	20816-20817	:	_
115-51	20818-20822	Task	_
115-52	20823-20832	switching	_
115-53	20833-20837	task	_
115-54	20838-20841	bht	_
115-55	20842-20843	:	_
115-56	20844-20858	Breath-holding	_
115-57	20859-20863	task	_
115-58	20864-20868	rest	_
115-59	20869-20870	:	_
115-60	20871-20878	Resting	_
115-61	20879-20884	state	_
115-62	20885-20886	(	_
115-63	20887-20891	eyes	_
115-64	20892-20896	open	_
115-65	20897-20898	)	_
115-66	20899-20902	The	_
115-67	20903-20908	label	_
115-68	20909-20910	<	_
115-69	20911-20919	taskname	_
115-70	20920-20921	>	_
115-71	20922-20928	refers	_
115-72	20929-20931	to	_
115-73	20932-20936	data	_
115-74	20937-20941	from	_
115-75	20942-20945	one	_
115-76	20946-20948	of	_
115-77	20949-20952	the	_
115-78	20953-20958	tasks	_
115-79	20959-20968	performed	_
115-80	20969-20975	during	_
115-81	20976-20979	the	_
115-82	20980-20985	visit	_
115-83	20986-20987	:	_
115-84	20988-20990	An	_
115-85	20991-21001	additional	_
115-86	21002-21011	directory	_
115-87	21012-21017	named	_
115-88	21018-21019	‘	_
115-89	21020-21029	phenotype	_
115-90	21030-21031	’	_
115-91	21032-21040	contains	_
115-92	21041-21051	additional	_
115-93	21052-21062	phenotypic	_
115-94	21063-21074	information	_
115-95	21075-21076	(	_
115-96	21077-21081	such	_
115-97	21082-21084	as	_
115-98	21085-21103	neuropsychological	_
115-99	21104-21111	testing	_
115-100	21112-21119	results	_
115-101	21120-21121	)	_
115-102	21122-21123	;	_
115-103	21124-21127	for	_
115-104	21128-21132	each	_
115-105	21133-21144	measurement	_
115-106	21145-21146	,	_
115-107	21147-21152	there	_
115-108	21153-21155	is	_
115-109	21156-21157	a	_
115-110	21158-21171	tab-delimited	_
115-111	21172-21176	text	_
115-112	21177-21181	file	_
115-113	21182-21187	along	_
115-114	21188-21192	with	_
115-115	21193-21194	a	_
115-116	21195-21199	JSON	_
115-117	21200-21204	file	_
115-118	21205-21215	containing	_
115-119	21216-21219	the	_
115-120	21220-21224	data	_
115-121	21225-21235	dictionary	_
115-122	21236-21239	and	_
115-123	21240-21257	measurement-level	_
115-124	21258-21266	metadata	_
115-125	21267-21268	.	_

Text=Technical Validation Imaging files were converted from primary DICOM data to Neuroimaging Informatics Technology Initiative (NIfTI) version 1.1 format using the dcm2niix (https: //github.com/neurolabusc/dcm2niix) program.
116-1	21269-21278	Technical	_
116-2	21279-21289	Validation	_
116-3	21290-21297	Imaging	_
116-4	21298-21303	files	_
116-5	21304-21308	were	_
116-6	21309-21318	converted	_
116-7	21319-21323	from	_
116-8	21324-21331	primary	_
116-9	21332-21337	DICOM	_
116-10	21338-21342	data	_
116-11	21343-21345	to	_
116-12	21346-21358	Neuroimaging	_
116-13	21359-21370	Informatics	_
116-14	21371-21381	Technology	_
116-15	21382-21392	Initiative	_
116-16	21393-21394	(	_
116-17	21395-21400	NIfTI	_
116-18	21401-21402	)	_
116-19	21403-21410	version	_
116-20	21411-21414	1.1	_
116-21	21415-21421	format	_
116-22	21422-21427	using	_
116-23	21428-21431	the	_
116-24	21432-21440	dcm2niix	_
116-25	21441-21442	(	_
116-26	21443-21448	https	_
116-27	21449-21450	:	_
116-28	21451-21484	//github.com/neurolabusc/dcm2niix	_
116-29	21485-21486	)	_
116-30	21487-21494	program	_
116-31	21495-21496	.	_

Text=dcm2niix extracts the image pixel data and pertinent metadata parameters from the DICOM files to populate the NIfTI file header.
117-1	21497-21505	dcm2niix	_
117-2	21506-21514	extracts	_
117-3	21515-21518	the	_
117-4	21519-21524	image	_
117-5	21525-21530	pixel	_
117-6	21531-21535	data	_
117-7	21536-21539	and	_
117-8	21540-21549	pertinent	_
117-9	21550-21558	metadata	_
117-10	21559-21569	parameters	_
117-11	21570-21574	from	_
117-12	21575-21578	the	_
117-13	21579-21584	DICOM	_
117-14	21585-21590	files	_
117-15	21591-21593	to	_
117-16	21594-21602	populate	_
117-17	21603-21606	the	_
117-18	21607-21612	NIfTI	_
117-19	21613-21617	file	_
117-20	21618-21624	header	_
117-21	21625-21626	.	_

Text=For diffusion weighted images, dcm2niix also extracts the diffusion gradient strengths and orientations to separate files.
118-1	21627-21630	For	_
118-2	21631-21640	diffusion	_
118-3	21641-21649	weighted	_
118-4	21650-21656	images	_
118-5	21657-21658	,	_
118-6	21659-21667	dcm2niix	_
118-7	21668-21672	also	_
118-8	21673-21681	extracts	_
118-9	21682-21685	the	_
118-10	21686-21695	diffusion	_
118-11	21696-21704	gradient	_
118-12	21705-21714	strengths	_
118-13	21715-21718	and	_
118-14	21719-21731	orientations	_
118-15	21732-21734	to	_
118-16	21735-21743	separate	_
118-17	21744-21749	files	_
118-18	21750-21751	.	_

Text=The dcm2niix program output was saved for each conversion and inspected for errors.
119-1	21752-21755	The	_
119-2	21756-21764	dcm2niix	_
119-3	21765-21772	program	_
119-4	21773-21779	output	_
119-5	21780-21783	was	_
119-6	21784-21789	saved	_
119-7	21790-21793	for	_
119-8	21794-21798	each	_
119-9	21799-21809	conversion	_
119-10	21810-21813	and	_
119-11	21814-21823	inspected	_
119-12	21824-21827	for	_
119-13	21828-21834	errors	_
119-14	21835-21836	.	_

Text=Additional metadata were extracted from the DICOM files using the gdcm library (http: //gdcm.sourceforge.net/wiki/index.php/Main_Page) and converted to javascript object notation (JSON) format to accompany the respective image files.
120-1	21837-21847	Additional	_
120-2	21848-21856	metadata	_
120-3	21857-21861	were	_
120-4	21862-21871	extracted	_
120-5	21872-21876	from	_
120-6	21877-21880	the	_
120-7	21881-21886	DICOM	_
120-8	21887-21892	files	_
120-9	21893-21898	using	_
120-10	21899-21902	the	_
120-11	21903-21907	gdcm	_
120-12	21908-21915	library	_
120-13	21916-21917	(	_
120-14	21918-21922	http	_
120-15	21923-21924	:	_
120-16	21925-21972	//gdcm.sourceforge.net/wiki/index.php/Main_Page	_
120-17	21973-21974	)	_
120-18	21975-21978	and	_
120-19	21979-21988	converted	_
120-20	21989-21991	to	_
120-21	21992-22002	javascript	_
120-22	22003-22009	object	_
120-23	22010-22018	notation	_
120-24	22019-22020	(	_
120-25	22021-22025	JSON	_
120-26	22026-22027	)	_
120-27	22028-22034	format	_
120-28	22035-22037	to	_
120-29	22038-22047	accompany	_
120-30	22048-22051	the	_
120-31	22052-22062	respective	_
120-32	22063-22068	image	_
120-33	22069-22074	files	_
120-34	22075-22076	.	_

Text=All relevant metadata were combined and plotted over the timeframe of the study to reveal instances where individual scans were performed with MRI parameter settings that deviated from the standard protocol and to highlight scans with non-standard dimensions.
121-1	22077-22080	All	_
121-2	22081-22089	relevant	_
121-3	22090-22098	metadata	_
121-4	22099-22103	were	_
121-5	22104-22112	combined	_
121-6	22113-22116	and	_
121-7	22117-22124	plotted	_
121-8	22125-22129	over	_
121-9	22130-22133	the	_
121-10	22134-22143	timeframe	_
121-11	22144-22146	of	_
121-12	22147-22150	the	_
121-13	22151-22156	study	_
121-14	22157-22159	to	_
121-15	22160-22166	reveal	_
121-16	22167-22176	instances	_
121-17	22177-22182	where	_
121-18	22183-22193	individual	_
121-19	22194-22199	scans	_
121-20	22200-22204	were	_
121-21	22205-22214	performed	_
121-22	22215-22219	with	_
121-23	22220-22223	MRI	_
121-24	22224-22233	parameter	_
121-25	22234-22242	settings	_
121-26	22243-22247	that	_
121-27	22248-22256	deviated	_
121-28	22257-22261	from	_
121-29	22262-22265	the	_
121-30	22266-22274	standard	_
121-31	22275-22283	protocol	_
121-32	22284-22287	and	_
121-33	22288-22290	to	_
121-34	22291-22300	highlight	_
121-35	22301-22306	scans	_
121-36	22307-22311	with	_
121-37	22312-22324	non-standard	_
121-38	22325-22335	dimensions	_
121-39	22336-22337	.	_

Text=There were very few deviations, and most were minor in nature that did not warrant data exclusion; however the table of parameters and plots are included with the data set as reference material.
122-1	22338-22343	There	_
122-2	22344-22348	were	_
122-3	22349-22353	very	_
122-4	22354-22357	few	_
122-5	22358-22368	deviations	_
122-6	22369-22370	,	_
122-7	22371-22374	and	_
122-8	22375-22379	most	_
122-9	22380-22384	were	_
122-10	22385-22390	minor	_
122-11	22391-22393	in	_
122-12	22394-22400	nature	_
122-13	22401-22405	that	_
122-14	22406-22409	did	_
122-15	22410-22413	not	_
122-16	22414-22421	warrant	_
122-17	22422-22426	data	_
122-18	22427-22436	exclusion	_
122-19	22437-22438	;	_
122-20	22439-22446	however	_
122-21	22447-22450	the	_
122-22	22451-22456	table	_
122-23	22457-22459	of	_
122-24	22460-22470	parameters	_
122-25	22471-22474	and	_
122-26	22475-22480	plots	_
122-27	22481-22484	are	_
122-28	22485-22493	included	_
122-29	22494-22498	with	_
122-30	22499-22502	the	_
122-31	22503-22507	data	_
122-32	22508-22511	set	_
122-33	22512-22514	as	_
122-34	22515-22524	reference	_
122-35	22525-22533	material	_
122-36	22534-22535	.	_

Text=After processing the source data, BOLD contrast (fMRI) and T1-weighted anatomical imaging data were processed by the MRI Quality Control protocol (MRIQC https: //github.com/poldracklab/mriqc).
123-1	22536-22541	After	_
123-2	22542-22552	processing	_
123-3	22553-22556	the	_
123-4	22557-22563	source	_
123-5	22564-22568	data	_
123-6	22569-22570	,	_
123-7	22571-22575	BOLD	_
123-8	22576-22584	contrast	_
123-9	22585-22586	(	_
123-10	22587-22591	fMRI	_
123-11	22592-22593	)	_
123-12	22594-22597	and	_
123-13	22598-22609	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
123-14	22610-22620	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
123-15	22621-22628	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
123-16	22629-22633	data	_
123-17	22634-22638	were	_
123-18	22639-22648	processed	_
123-19	22649-22651	by	_
123-20	22652-22655	the	_
123-21	22656-22659	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
123-22	22660-22667	Quality	_
123-23	22668-22675	Control	_
123-24	22676-22684	protocol	_
123-25	22685-22686	(	_
123-26	22687-22692	MRIQC	_
123-27	22693-22698	https	_
123-28	22699-22700	:	_
123-29	22701-22731	//github.com/poldracklab/mriqc	_
123-30	22732-22733	)	_
123-31	22734-22735	.	_

Text=MRIQC computes several quality control metrics available in the published literature.
124-1	22736-22741	MRIQC	_
124-2	22742-22750	computes	_
124-3	22751-22758	several	_
124-4	22759-22766	quality	_
124-5	22767-22774	control	_
124-6	22775-22782	metrics	_
124-7	22783-22792	available	_
124-8	22793-22795	in	_
124-9	22796-22799	the	_
124-10	22800-22809	published	_
124-11	22810-22820	literature	_
124-12	22821-22822	.	_

Text=Anatomical T1w scans All T1-weighted images were skull-stripped [AFNI 3dSkullStrip], corrected for intensity inhomogeneity due to B1 variations [ANTS N4], and normalized to MNI-152 2 mm template space [ANTS].
125-1	22823-22833	Anatomical	_
125-2	22834-22837	T1w	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
125-3	22838-22843	scans	_
125-4	22844-22847	All	_
125-5	22848-22859	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
125-6	22860-22866	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
125-7	22867-22871	were	_
125-8	22872-22886	skull-stripped	_
125-9	22887-22888	[	_
125-10	22889-22893	AFNI	_
125-11	22894-22906	3dSkullStrip	_
125-12	22907-22908	]	_
125-13	22909-22910	,	_
125-14	22911-22920	corrected	_
125-15	22921-22924	for	_
125-16	22925-22934	intensity	_
125-17	22935-22948	inhomogeneity	_
125-18	22949-22952	due	_
125-19	22953-22955	to	_
125-20	22956-22958	B1	_
125-21	22959-22969	variations	_
125-22	22970-22971	[	_
125-23	22972-22976	ANTS	_
125-24	22977-22979	N4	_
125-25	22980-22981	]	_
125-26	22982-22983	,	_
125-27	22984-22987	and	_
125-28	22988-22998	normalized	_
125-29	22999-23001	to	_
125-30	23002-23009	MNI-152	_
125-31	23010-23011	2	_
125-32	23012-23014	mm	_
125-33	23015-23023	template	_
125-34	23024-23029	space	_
125-35	23030-23031	[	_
125-36	23032-23036	ANTS	_
125-37	23037-23038	]	_
125-38	23039-23040	.	_

Text=The background, gray matter, white matter, and cerebrospinal fluid were segmented [FSL 5.0.8/FAST], and the resulting segmentations were used to compute the a set of quality control measures (See Table 4).
126-1	23041-23044	The	_
126-2	23045-23055	background	_
126-3	23056-23057	,	_
126-4	23058-23062	gray	_
126-5	23063-23069	matter	_
126-6	23070-23071	,	_
126-7	23072-23077	white	_
126-8	23078-23084	matter	_
126-9	23085-23086	,	_
126-10	23087-23090	and	_
126-11	23091-23104	cerebrospinal	_
126-12	23105-23110	fluid	_
126-13	23111-23115	were	_
126-14	23116-23125	segmented	_
126-15	23126-23127	[	_
126-16	23128-23131	FSL	_
126-17	23132-23142	5.0.8/FAST	_
126-18	23143-23144	]	_
126-19	23145-23146	,	_
126-20	23147-23150	and	_
126-21	23151-23154	the	_
126-22	23155-23164	resulting	_
126-23	23165-23178	segmentations	_
126-24	23179-23183	were	_
126-25	23184-23188	used	_
126-26	23189-23191	to	_
126-27	23192-23199	compute	_
126-28	23200-23203	the	_
126-29	23204-23205	a	_
126-30	23206-23209	set	_
126-31	23210-23212	of	_
126-32	23213-23220	quality	_
126-33	23221-23228	control	_
126-34	23229-23237	measures	_
126-35	23238-23239	(	_
126-36	23240-23243	See	_
126-37	23244-23249	Table	_
126-38	23250-23251	4	_
126-39	23252-23253	)	_
126-40	23254-23255	.	_

Text=In addition to the quality metrics listed above, summary information about the mean and standard deviation of background, foreground, gray matter, white matter, CSF, and average inhomogeneity bias are provided for comparison across the subject population (see Fig.
127-1	23256-23258	In	_
127-2	23259-23267	addition	_
127-3	23268-23270	to	_
127-4	23271-23274	the	_
127-5	23275-23282	quality	_
127-6	23283-23290	metrics	_
127-7	23291-23297	listed	_
127-8	23298-23303	above	_
127-9	23304-23305	,	_
127-10	23306-23313	summary	_
127-11	23314-23325	information	_
127-12	23326-23331	about	_
127-13	23332-23335	the	_
127-14	23336-23340	mean	_
127-15	23341-23344	and	_
127-16	23345-23353	standard	_
127-17	23354-23363	deviation	_
127-18	23364-23366	of	_
127-19	23367-23377	background	_
127-20	23378-23379	,	_
127-21	23380-23390	foreground	_
127-22	23391-23392	,	_
127-23	23393-23397	gray	_
127-24	23398-23404	matter	_
127-25	23405-23406	,	_
127-26	23407-23412	white	_
127-27	23413-23419	matter	_
127-28	23420-23421	,	_
127-29	23422-23425	CSF	_
127-30	23426-23427	,	_
127-31	23428-23431	and	_
127-32	23432-23439	average	_
127-33	23440-23453	inhomogeneity	_
127-34	23454-23458	bias	_
127-35	23459-23462	are	_
127-36	23463-23471	provided	_
127-37	23472-23475	for	_
127-38	23476-23486	comparison	_
127-39	23487-23493	across	_
127-40	23494-23497	the	_
127-41	23498-23505	subject	_
127-42	23506-23516	population	_
127-43	23517-23518	(	_
127-44	23519-23522	see	_
127-45	23523-23526	Fig	_
127-46	23527-23528	.	_

Text=1).
128-1	23529-23530	1	_
128-2	23531-23532	)	_
128-3	23533-23534	.	_

Text=After the MRIQC was completed, each high-resolution T1-weighted anatomical scan was scrubbed of facial features using the mri_deface program.
129-1	23535-23540	After	_
129-2	23541-23544	the	_
129-3	23545-23550	MRIQC	http://maven.renci.org/NeuroBridge/neurobridge#Thing
129-4	23551-23554	was	_
129-5	23555-23564	completed	_
129-6	23565-23566	,	_
129-7	23567-23571	each	_
129-8	23572-23587	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
129-9	23588-23599	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
129-10	23600-23610	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
129-11	23611-23615	scan	_
129-12	23616-23619	was	_
129-13	23620-23628	scrubbed	_
129-14	23629-23631	of	_
129-15	23632-23638	facial	_
129-16	23639-23647	features	_
129-17	23648-23653	using	_
129-18	23654-23657	the	_
129-19	23658-23668	mri_deface	_
129-20	23669-23676	program	_
129-21	23677-23678	.	_

Text=Visual inspection of all outputs was performed to ensure that the facial features were properly removed to preserve subject privacy.
130-1	23679-23685	Visual	_
130-2	23686-23696	inspection	_
130-3	23697-23699	of	_
130-4	23700-23703	all	_
130-5	23704-23711	outputs	_
130-6	23712-23715	was	_
130-7	23716-23725	performed	_
130-8	23726-23728	to	_
130-9	23729-23735	ensure	_
130-10	23736-23740	that	_
130-11	23741-23744	the	_
130-12	23745-23751	facial	_
130-13	23752-23760	features	_
130-14	23761-23765	were	_
130-15	23766-23774	properly	_
130-16	23775-23782	removed	_
130-17	23783-23785	to	_
130-18	23786-23794	preserve	_
130-19	23795-23802	subject	_
130-20	23803-23810	privacy	_
130-21	23811-23812	.	_

Text=BOLD/T2 * -weighted functional scans Each BOLD-contrast fMRI scan was corrected for head motion during the acquisition using AFNI, and a brain mask was computed to separate the brain from the skull and outside air.
131-1	23813-23820	BOLD/T2	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
131-2	23821-23822	*	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
131-3	23823-23832	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
131-4	23833-23843	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
131-5	23844-23849	scans	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
131-6	23850-23854	Each	_
131-7	23855-23868	BOLD-contrast	_
131-8	23869-23873	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
131-9	23874-23878	scan	_
131-10	23879-23882	was	_
131-11	23883-23892	corrected	_
131-12	23893-23896	for	_
131-13	23897-23901	head	_
131-14	23902-23908	motion	_
131-15	23909-23915	during	_
131-16	23916-23919	the	_
131-17	23920-23931	acquisition	_
131-18	23932-23937	using	_
131-19	23938-23942	AFNI	_
131-20	23943-23944	,	_
131-21	23945-23948	and	_
131-22	23949-23950	a	_
131-23	23951-23956	brain	_
131-24	23957-23961	mask	_
131-25	23962-23965	was	_
131-26	23966-23974	computed	_
131-27	23975-23977	to	_
131-28	23978-23986	separate	_
131-29	23987-23990	the	_
131-30	23991-23996	brain	_
131-31	23997-24001	from	_
131-32	24002-24005	the	_
131-33	24006-24011	skull	_
131-34	24012-24015	and	_
131-35	24016-24023	outside	_
131-36	24024-24027	air	_
131-37	24028-24029	.	_

Text=Table 5 lists the QC metrics that were were computed from these images, and Fig.
132-1	24030-24035	Table	_
132-2	24036-24037	5	_
132-3	24038-24043	lists	_
132-4	24044-24047	the	_
132-5	24048-24050	QC	_
132-6	24051-24058	metrics	_
132-7	24059-24063	that	_
132-8	24064-24068	were	_
132-9	24069-24073	were	_
132-10	24074-24082	computed	_
132-11	24083-24087	from	_
132-12	24088-24093	these	_
132-13	24094-24100	images	_
132-14	24101-24102	,	_
132-15	24103-24106	and	_
132-16	24107-24110	Fig	_
132-17	24111-24112	.	_

Text=2 shows the distribution of these measures.
133-1	24113-24114	2	_
133-2	24115-24120	shows	_
133-3	24121-24124	the	_
133-4	24125-24137	distribution	_
133-5	24138-24140	of	_
133-6	24141-24146	these	_
133-7	24147-24155	measures	_
133-8	24156-24157	.	_

Text=fMRI task event and physiological monitoring data fMRI task and event onsets were extracted from the raw matlab log files using R-matlab and are provided as tabular text files.
134-1	24158-24162	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
134-2	24163-24167	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
134-3	24168-24173	event	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
134-4	24174-24177	and	_
134-5	24178-24191	physiological	_
134-6	24192-24202	monitoring	_
134-7	24203-24207	data	_
134-8	24208-24212	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
134-9	24213-24217	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
134-10	24218-24221	and	_
134-11	24222-24227	event	_
134-12	24228-24234	onsets	_
134-13	24235-24239	were	_
134-14	24240-24249	extracted	_
134-15	24250-24254	from	_
134-16	24255-24258	the	_
134-17	24259-24262	raw	_
134-18	24263-24269	matlab	_
134-19	24270-24273	log	_
134-20	24274-24279	files	_
134-21	24280-24285	using	_
134-22	24286-24294	R-matlab	_
134-23	24295-24298	and	_
134-24	24299-24302	are	_
134-25	24303-24311	provided	_
134-26	24312-24314	as	_
134-27	24315-24322	tabular	_
134-28	24323-24327	text	_
134-29	24328-24333	files	_
134-30	24334-24335	.	_

Text=These event files contain the onset, duration, type of trial, reaction time, and task-specific details.
135-1	24336-24341	These	_
135-2	24342-24347	event	_
135-3	24348-24353	files	_
135-4	24354-24361	contain	_
135-5	24362-24365	the	_
135-6	24366-24371	onset	_
135-7	24372-24373	,	_
135-8	24374-24382	duration	_
135-9	24383-24384	,	_
135-10	24385-24389	type	_
135-11	24390-24392	of	_
135-12	24393-24398	trial	_
135-13	24399-24400	,	_
135-14	24401-24409	reaction	_
135-15	24410-24414	time	_
135-16	24415-24416	,	_
135-17	24417-24420	and	_
135-18	24421-24434	task-specific	_
135-19	24435-24442	details	_
135-20	24443-24444	.	_

Text=The onset time entries in each event file were corrected for the scanner trigger delay to account for extra T1 saturation equalization pre-scans performed by the scanner.
136-1	24445-24448	The	_
136-2	24449-24454	onset	_
136-3	24455-24459	time	_
136-4	24460-24467	entries	_
136-5	24468-24470	in	_
136-6	24471-24475	each	_
136-7	24476-24481	event	_
136-8	24482-24486	file	_
136-9	24487-24491	were	_
136-10	24492-24501	corrected	_
136-11	24502-24505	for	_
136-12	24506-24509	the	_
136-13	24510-24517	scanner	_
136-14	24518-24525	trigger	_
136-15	24526-24531	delay	_
136-16	24532-24534	to	_
136-17	24535-24542	account	_
136-18	24543-24546	for	_
136-19	24547-24552	extra	_
136-20	24553-24555	T1	_
136-21	24556-24566	saturation	_
136-22	24567-24579	equalization	_
136-23	24580-24589	pre-scans	_
136-24	24590-24599	performed	_
136-25	24600-24602	by	_
136-26	24603-24606	the	_
136-27	24607-24614	scanner	_
136-28	24615-24616	.	_

Text=In some cases the trigger delay was not explicitly available from the source data.
137-1	24617-24619	In	_
137-2	24620-24624	some	_
137-3	24625-24630	cases	_
137-4	24631-24634	the	_
137-5	24635-24642	trigger	_
137-6	24643-24648	delay	_
137-7	24649-24652	was	_
137-8	24653-24656	not	_
137-9	24657-24667	explicitly	_
137-10	24668-24677	available	_
137-11	24678-24682	from	_
137-12	24683-24686	the	_
137-13	24687-24693	source	_
137-14	24694-24698	data	_
137-15	24699-24700	.	_

Text=Plots of all event files are provided with the data set for reference.
138-1	24701-24706	Plots	_
138-2	24707-24709	of	_
138-3	24710-24713	all	_
138-4	24714-24719	event	_
138-5	24720-24725	files	_
138-6	24726-24729	are	_
138-7	24730-24738	provided	_
138-8	24739-24743	with	_
138-9	24744-24747	the	_
138-10	24748-24752	data	_
138-11	24753-24756	set	_
138-12	24757-24760	for	_
138-13	24761-24770	reference	_
138-14	24771-24772	.	_

Text=Similarly, physiological recordings collected during resting state and breath-holding fMRI scans were converted from raw data (Acknowledge format, BioPac) using the Bioread python package (https: //github.com/njvack/bioread).
139-1	24773-24782	Similarly	_
139-2	24783-24784	,	_
139-3	24785-24798	physiological	_
139-4	24799-24809	recordings	_
139-5	24810-24819	collected	_
139-6	24820-24826	during	_
139-7	24827-24834	resting	_
139-8	24835-24840	state	_
139-9	24841-24844	and	_
139-10	24845-24859	breath-holding	_
139-11	24860-24864	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
139-12	24865-24870	scans	_
139-13	24871-24875	were	_
139-14	24876-24885	converted	_
139-15	24886-24890	from	_
139-16	24891-24894	raw	_
139-17	24895-24899	data	_
139-18	24900-24901	(	_
139-19	24902-24913	Acknowledge	_
139-20	24914-24920	format	_
139-21	24921-24922	,	_
139-22	24923-24929	BioPac	_
139-23	24930-24931	)	_
139-24	24932-24937	using	_
139-25	24938-24941	the	_
139-26	24942-24949	Bioread	_
139-27	24950-24956	python	_
139-28	24957-24964	package	_
139-29	24965-24966	(	_
139-30	24967-24972	https	_
139-31	24973-24974	:	_
139-32	24975-25002	//github.com/njvack/bioread	_
139-33	25003-25004	)	_
139-34	25005-25006	.	_

Text=The individual recording traces were saved as gzip-compressed tab-separated value files, and the raw data header information (Channel Name, Units, Sampling Rate) was extracted to accompanying JSON files.
140-1	25007-25010	The	_
140-2	25011-25021	individual	_
140-3	25022-25031	recording	_
140-4	25032-25038	traces	_
140-5	25039-25043	were	_
140-6	25044-25049	saved	_
140-7	25050-25052	as	_
140-8	25053-25068	gzip-compressed	_
140-9	25069-25082	tab-separated	_
140-10	25083-25088	value	_
140-11	25089-25094	files	_
140-12	25095-25096	,	_
140-13	25097-25100	and	_
140-14	25101-25104	the	_
140-15	25105-25108	raw	_
140-16	25109-25113	data	_
140-17	25114-25120	header	_
140-18	25121-25132	information	_
140-19	25133-25134	(	_
140-20	25135-25142	Channel	_
140-21	25143-25147	Name	_
140-22	25148-25149	,	_
140-23	25150-25155	Units	_
140-24	25156-25157	,	_
140-25	25158-25166	Sampling	_
140-26	25167-25171	Rate	_
140-27	25172-25173	)	_
140-28	25174-25177	was	_
140-29	25178-25187	extracted	_
140-30	25188-25190	to	_
140-31	25191-25203	accompanying	_
140-32	25204-25208	JSON	_
140-33	25209-25214	files	_
140-34	25215-25216	.	_

Text=Plots of physiological traces are provided overlaid with breath-hold instruction timings (ready, hold, rest) for reference.
141-1	25217-25222	Plots	_
141-2	25223-25225	of	_
141-3	25226-25239	physiological	_
141-4	25240-25246	traces	_
141-5	25247-25250	are	_
141-6	25251-25259	provided	_
141-7	25260-25268	overlaid	_
141-8	25269-25273	with	_
141-9	25274-25285	breath-hold	_
141-10	25286-25297	instruction	_
141-11	25298-25305	timings	_
141-12	25306-25307	(	_
141-13	25308-25313	ready	_
141-14	25314-25315	,	_
141-15	25316-25320	hold	_
141-16	25321-25322	,	_
141-17	25323-25327	rest	_
141-18	25328-25329	)	_
141-19	25330-25333	for	_
141-20	25334-25343	reference	_
141-21	25344-25345	.	_

Text=Diffusion-weighted imaging The diffusion-weighted data were corrected for eddy currents and head motion using the B0 image as the reference, and the motion parameters were saved for later analysis.
142-1	25346-25364	Diffusion-weighted	_
142-2	25365-25372	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
142-3	25373-25376	The	_
142-4	25377-25395	diffusion-weighted	_
142-5	25396-25400	data	_
142-6	25401-25405	were	_
142-7	25406-25415	corrected	_
142-8	25416-25419	for	_
142-9	25420-25424	eddy	_
142-10	25425-25433	currents	_
142-11	25434-25437	and	_
142-12	25438-25442	head	_
142-13	25443-25449	motion	_
142-14	25450-25455	using	_
142-15	25456-25459	the	_
142-16	25460-25462	B0	_
142-17	25463-25468	image	_
142-18	25469-25471	as	_
142-19	25472-25475	the	_
142-20	25476-25485	reference	_
142-21	25486-25487	,	_
142-22	25488-25491	and	_
142-23	25492-25495	the	_
142-24	25496-25502	motion	_
142-25	25503-25513	parameters	_
142-26	25514-25518	were	_
142-27	25519-25524	saved	_
142-28	25525-25528	for	_
142-29	25529-25534	later	_
142-30	25535-25543	analysis	_
142-31	25544-25545	.	_

Text=The corrected volumes were then skull-stripped to remove the background and other non-brain scan regions.
143-1	25546-25549	The	_
143-2	25550-25559	corrected	_
143-3	25560-25567	volumes	_
143-4	25568-25572	were	_
143-5	25573-25577	then	_
143-6	25578-25592	skull-stripped	_
143-7	25593-25595	to	_
143-8	25596-25602	remove	_
143-9	25603-25606	the	_
143-10	25607-25617	background	_
143-11	25618-25621	and	_
143-12	25622-25627	other	_
143-13	25628-25637	non-brain	_
143-14	25638-25642	scan	_
143-15	25643-25650	regions	_
143-16	25651-25652	.	_

Text=Diffusion tensor estimation was performed for each subject, and the mean fractional anisotropy (FA) and average diffusivity (AD) were computed for all brain voxels.
144-1	25653-25662	Diffusion	_
144-2	25663-25669	tensor	_
144-3	25670-25680	estimation	_
144-4	25681-25684	was	_
144-5	25685-25694	performed	_
144-6	25695-25698	for	_
144-7	25699-25703	each	_
144-8	25704-25711	subject	_
144-9	25712-25713	,	_
144-10	25714-25717	and	_
144-11	25718-25721	the	_
144-12	25722-25726	mean	_
144-13	25727-25737	fractional	_
144-14	25738-25748	anisotropy	_
144-15	25749-25750	(	_
144-16	25751-25753	FA	_
144-17	25754-25755	)	_
144-18	25756-25759	and	_
144-19	25760-25767	average	_
144-20	25768-25779	diffusivity	_
144-21	25780-25781	(	_
144-22	25782-25784	AD	_
144-23	25785-25786	)	_
144-24	25787-25791	were	_
144-25	25792-25800	computed	_
144-26	25801-25804	for	_
144-27	25805-25808	all	_
144-28	25809-25814	brain	_
144-29	25815-25821	voxels	_
144-30	25822-25823	.	_

Text=Quality assurance was performed using a semi-automated method, including the following steps: confirmed that the b-values and applied directions were the same as expected, calculated mean in-mask FA and average or mean diffusivity (AD, MD), calculated and plotted motion, created a standard deviation image based on regular and motion corrected files, and used regional maps to calculate the percentage of cropped voxels in the occipital lobe, frontal lobe, temporal lobes, cerebellum, and the most superior portion of the brain.
145-1	25824-25831	Quality	_
145-2	25832-25841	assurance	_
145-3	25842-25845	was	_
145-4	25846-25855	performed	_
145-5	25856-25861	using	_
145-6	25862-25863	a	_
145-7	25864-25878	semi-automated	_
145-8	25879-25885	method	_
145-9	25886-25887	,	_
145-10	25888-25897	including	_
145-11	25898-25901	the	_
145-12	25902-25911	following	_
145-13	25912-25917	steps	_
145-14	25918-25919	:	_
145-15	25920-25929	confirmed	_
145-16	25930-25934	that	_
145-17	25935-25938	the	_
145-18	25939-25947	b-values	_
145-19	25948-25951	and	_
145-20	25952-25959	applied	_
145-21	25960-25970	directions	_
145-22	25971-25975	were	_
145-23	25976-25979	the	_
145-24	25980-25984	same	_
145-25	25985-25987	as	_
145-26	25988-25996	expected	_
145-27	25997-25998	,	_
145-28	25999-26009	calculated	_
145-29	26010-26014	mean	_
145-30	26015-26022	in-mask	_
145-31	26023-26025	FA	_
145-32	26026-26029	and	_
145-33	26030-26037	average	_
145-34	26038-26040	or	_
145-35	26041-26045	mean	_
145-36	26046-26057	diffusivity	_
145-37	26058-26059	(	_
145-38	26060-26062	AD	_
145-39	26063-26064	,	_
145-40	26065-26067	MD	_
145-41	26068-26069	)	_
145-42	26070-26071	,	_
145-43	26072-26082	calculated	_
145-44	26083-26086	and	_
145-45	26087-26094	plotted	_
145-46	26095-26101	motion	_
145-47	26102-26103	,	_
145-48	26104-26111	created	_
145-49	26112-26113	a	_
145-50	26114-26122	standard	_
145-51	26123-26132	deviation	_
145-52	26133-26138	image	_
145-53	26139-26144	based	_
145-54	26145-26147	on	_
145-55	26148-26155	regular	_
145-56	26156-26159	and	_
145-57	26160-26166	motion	_
145-58	26167-26176	corrected	_
145-59	26177-26182	files	_
145-60	26183-26184	,	_
145-61	26185-26188	and	_
145-62	26189-26193	used	_
145-63	26194-26202	regional	_
145-64	26203-26207	maps	_
145-65	26208-26210	to	_
145-66	26211-26220	calculate	_
145-67	26221-26224	the	_
145-68	26225-26235	percentage	_
145-69	26236-26238	of	_
145-70	26239-26246	cropped	_
145-71	26247-26253	voxels	_
145-72	26254-26256	in	_
145-73	26257-26260	the	_
145-74	26261-26270	occipital	_
145-75	26271-26275	lobe	_
145-76	26276-26277	,	_
145-77	26278-26285	frontal	_
145-78	26286-26290	lobe	_
145-79	26291-26292	,	_
145-80	26293-26301	temporal	_
145-81	26302-26307	lobes	_
145-82	26308-26309	,	_
145-83	26310-26320	cerebellum	_
145-84	26321-26322	,	_
145-85	26323-26326	and	_
145-86	26327-26330	the	_
145-87	26331-26335	most	_
145-88	26336-26344	superior	_
145-89	26345-26352	portion	_
145-90	26353-26355	of	_
145-91	26356-26359	the	_
145-92	26360-26365	brain	_
145-93	26366-26367	.	_

Text=Trained individuals then used the results of this script to evaluate scan quality.
146-1	26368-26375	Trained	_
146-2	26376-26387	individuals	_
146-3	26388-26392	then	_
146-4	26393-26397	used	_
146-5	26398-26401	the	_
146-6	26402-26409	results	_
146-7	26410-26412	of	_
146-8	26413-26417	this	_
146-9	26418-26424	script	_
146-10	26425-26427	to	_
146-11	26428-26436	evaluate	_
146-12	26437-26441	scan	_
146-13	26442-26449	quality	_
146-14	26450-26451	.	_

Text=This included a visual inspection of the FA map, visual inspection of the color map to ensure tracts were coded correctly, a check for cropping in which if more than 10 percent of voxels in a region were cropped, the map was visually inspected to ensure that the cropped region did not encroach on a major tract (i.e., regions that would be included in the FSL DTI skeleton), and the raw data were watched as a movie.
147-1	26452-26456	This	_
147-2	26457-26465	included	_
147-3	26466-26467	a	_
147-4	26468-26474	visual	_
147-5	26475-26485	inspection	_
147-6	26486-26488	of	_
147-7	26489-26492	the	_
147-8	26493-26495	FA	_
147-9	26496-26499	map	_
147-10	26500-26501	,	_
147-11	26502-26508	visual	_
147-12	26509-26519	inspection	_
147-13	26520-26522	of	_
147-14	26523-26526	the	_
147-15	26527-26532	color	_
147-16	26533-26536	map	_
147-17	26537-26539	to	_
147-18	26540-26546	ensure	_
147-19	26547-26553	tracts	_
147-20	26554-26558	were	_
147-21	26559-26564	coded	_
147-22	26565-26574	correctly	_
147-23	26575-26576	,	_
147-24	26577-26578	a	_
147-25	26579-26584	check	_
147-26	26585-26588	for	_
147-27	26589-26597	cropping	_
147-28	26598-26600	in	_
147-29	26601-26606	which	_
147-30	26607-26609	if	_
147-31	26610-26614	more	_
147-32	26615-26619	than	_
147-33	26620-26622	10	_
147-34	26623-26630	percent	_
147-35	26631-26633	of	_
147-36	26634-26640	voxels	_
147-37	26641-26643	in	_
147-38	26644-26645	a	_
147-39	26646-26652	region	_
147-40	26653-26657	were	_
147-41	26658-26665	cropped	_
147-42	26666-26667	,	_
147-43	26668-26671	the	_
147-44	26672-26675	map	_
147-45	26676-26679	was	_
147-46	26680-26688	visually	_
147-47	26689-26698	inspected	_
147-48	26699-26701	to	_
147-49	26702-26708	ensure	_
147-50	26709-26713	that	_
147-51	26714-26717	the	_
147-52	26718-26725	cropped	_
147-53	26726-26732	region	_
147-54	26733-26736	did	_
147-55	26737-26740	not	_
147-56	26741-26749	encroach	_
147-57	26750-26752	on	_
147-58	26753-26754	a	_
147-59	26755-26760	major	_
147-60	26761-26766	tract	_
147-61	26767-26768	(	_
147-62	26769-26773	i.e.	_
147-63	26774-26775	,	_
147-64	26776-26783	regions	_
147-65	26784-26788	that	_
147-66	26789-26794	would	_
147-67	26795-26797	be	_
147-68	26798-26806	included	_
147-69	26807-26809	in	_
147-70	26810-26813	the	_
147-71	26814-26817	FSL	_
147-72	26818-26821	DTI	_
147-73	26822-26830	skeleton	_
147-74	26831-26832	)	_
147-75	26833-26834	,	_
147-76	26835-26838	and	_
147-77	26839-26842	the	_
147-78	26843-26846	raw	_
147-79	26847-26851	data	_
147-80	26852-26856	were	_
147-81	26857-26864	watched	_
147-82	26865-26867	as	_
147-83	26868-26869	a	_
147-84	26870-26875	movie	_
147-85	26876-26877	.	_

Text=Data were flagged for coverage (0=no cropping, 1=minor cropping, 2=severe unuseable cropping), motion (based on watching raw data as movie, and on motion plots), tensor direction flags (based on b-value and direction calculations, and on observation of the color map), artifact flags (including noise, striping, and the vibration artifact that affected many Siemens Trio systems during this time period).
148-1	26878-26882	Data	_
148-2	26883-26887	were	_
148-3	26888-26895	flagged	_
148-4	26896-26899	for	_
148-5	26900-26908	coverage	_
148-6	26909-26910	(	_
148-7	26911-26915	0=no	_
148-8	26916-26924	cropping	_
148-9	26925-26926	,	_
148-10	26927-26934	1=minor	_
148-11	26935-26943	cropping	_
148-12	26944-26945	,	_
148-13	26946-26954	2=severe	_
148-14	26955-26964	unuseable	_
148-15	26965-26973	cropping	_
148-16	26974-26975	)	_
148-17	26976-26977	,	_
148-18	26978-26984	motion	_
148-19	26985-26986	(	_
148-20	26987-26992	based	_
148-21	26993-26995	on	_
148-22	26996-27004	watching	_
148-23	27005-27008	raw	_
148-24	27009-27013	data	_
148-25	27014-27016	as	_
148-26	27017-27022	movie	_
148-27	27023-27024	,	_
148-28	27025-27028	and	_
148-29	27029-27031	on	_
148-30	27032-27038	motion	_
148-31	27039-27044	plots	_
148-32	27045-27046	)	_
148-33	27047-27048	,	_
148-34	27049-27055	tensor	_
148-35	27056-27065	direction	_
148-36	27066-27071	flags	_
148-37	27072-27073	(	_
148-38	27074-27079	based	_
148-39	27080-27082	on	_
148-40	27083-27090	b-value	_
148-41	27091-27094	and	_
148-42	27095-27104	direction	_
148-43	27105-27117	calculations	_
148-44	27118-27119	,	_
148-45	27120-27123	and	_
148-46	27124-27126	on	_
148-47	27127-27138	observation	_
148-48	27139-27141	of	_
148-49	27142-27145	the	_
148-50	27146-27151	color	_
148-51	27152-27155	map	_
148-52	27156-27157	)	_
148-53	27158-27159	,	_
148-54	27160-27168	artifact	_
148-55	27169-27174	flags	_
148-56	27175-27176	(	_
148-57	27177-27186	including	_
148-58	27187-27192	noise	_
148-59	27193-27194	,	_
148-60	27195-27203	striping	_
148-61	27204-27205	,	_
148-62	27206-27209	and	_
148-63	27210-27213	the	_
148-64	27214-27223	vibration	_
148-65	27224-27232	artifact	_
148-66	27233-27237	that	_
148-67	27238-27246	affected	_
148-68	27247-27251	many	_
148-69	27252-27259	Siemens	_
148-70	27260-27264	Trio	_
148-71	27265-27272	systems	_
148-72	27273-27279	during	_
148-73	27280-27284	this	_
148-74	27285-27289	time	_
148-75	27290-27296	period	_
148-76	27297-27298	)	_
148-77	27299-27300	.	_

Text=An overall quality score from 1–4 was generated from these measures, in which 1=excellent, 2=good, 3=fair (both 2 and 3 may be useable, but depending on analysis may want to consider the reason for the decreased score), and 4=unuseable (all individuals with vibration artifacts are in this category, along with other irreconcilable problems), 5=not evaluated; the distribution of these ratings is shown in Fig.
149-1	27301-27303	An	_
149-2	27304-27311	overall	_
149-3	27312-27319	quality	_
149-4	27320-27325	score	_
149-5	27326-27330	from	_
149-6	27331-27334	1–4	_
149-7	27335-27338	was	_
149-8	27339-27348	generated	_
149-9	27349-27353	from	_
149-10	27354-27359	these	_
149-11	27360-27368	measures	_
149-12	27369-27370	,	_
149-13	27371-27373	in	_
149-14	27374-27379	which	_
149-15	27380-27391	1=excellent	_
149-16	27392-27393	,	_
149-17	27394-27400	2=good	_
149-18	27401-27402	,	_
149-19	27403-27409	3=fair	_
149-20	27410-27411	(	_
149-21	27412-27416	both	_
149-22	27417-27418	2	_
149-23	27419-27422	and	_
149-24	27423-27424	3	_
149-25	27425-27428	may	_
149-26	27429-27431	be	_
149-27	27432-27439	useable	_
149-28	27440-27441	,	_
149-29	27442-27445	but	_
149-30	27446-27455	depending	_
149-31	27456-27458	on	_
149-32	27459-27467	analysis	_
149-33	27468-27471	may	_
149-34	27472-27476	want	_
149-35	27477-27479	to	_
149-36	27480-27488	consider	_
149-37	27489-27492	the	_
149-38	27493-27499	reason	_
149-39	27500-27503	for	_
149-40	27504-27507	the	_
149-41	27508-27517	decreased	_
149-42	27518-27523	score	_
149-43	27524-27525	)	_
149-44	27526-27527	,	_
149-45	27528-27531	and	_
149-46	27532-27543	4=unuseable	_
149-47	27544-27545	(	_
149-48	27546-27549	all	_
149-49	27550-27561	individuals	_
149-50	27562-27566	with	_
149-51	27567-27576	vibration	_
149-52	27577-27586	artifacts	_
149-53	27587-27590	are	_
149-54	27591-27593	in	_
149-55	27594-27598	this	_
149-56	27599-27607	category	_
149-57	27608-27609	,	_
149-58	27610-27615	along	_
149-59	27616-27620	with	_
149-60	27621-27626	other	_
149-61	27627-27641	irreconcilable	_
149-62	27642-27650	problems	_
149-63	27651-27652	)	_
149-64	27653-27654	,	_
149-65	27655-27660	5=not	_
149-66	27661-27670	evaluated	_
149-67	27671-27672	;	_
149-68	27673-27676	the	_
149-69	27677-27689	distribution	_
149-70	27690-27692	of	_
149-71	27693-27698	these	_
149-72	27699-27706	ratings	_
149-73	27707-27709	is	_
149-74	27710-27715	shown	_
149-75	27716-27718	in	_
149-76	27719-27722	Fig	_
149-77	27723-27724	.	_

Text=3.
150-1	27725-27726	3	_
150-2	27727-27728	.	_

Text=Ratings are included with the data download.
151-1	27729-27736	Ratings	_
151-2	27737-27740	are	_
151-3	27741-27749	included	_
151-4	27750-27754	with	_
151-5	27755-27758	the	_
151-6	27759-27763	data	_
151-7	27764-27772	download	_
151-8	27773-27774	.	_

Text=Usage Notes All data are made available under the Public Domain Dedication and License v1.0 (http: //www.opendatacommons.org/licenses/pddl/1.0/), which places no restrictions on the usage of the data.
152-1	27775-27780	Usage	_
152-2	27781-27786	Notes	_
152-3	27787-27790	All	_
152-4	27791-27795	data	_
152-5	27796-27799	are	_
152-6	27800-27804	made	_
152-7	27805-27814	available	_
152-8	27815-27820	under	_
152-9	27821-27824	the	_
152-10	27825-27831	Public	_
152-11	27832-27838	Domain	_
152-12	27839-27849	Dedication	_
152-13	27850-27853	and	_
152-14	27854-27861	License	_
152-15	27862-27866	v1.0	_
152-16	27867-27868	(	_
152-17	27869-27873	http	_
152-18	27874-27875	:	_
152-19	27876-27920	//www.opendatacommons.org/licenses/pddl/1.0/	_
152-20	27921-27922	)	_
152-21	27923-27924	,	_
152-22	27925-27930	which	_
152-23	27931-27937	places	_
152-24	27938-27940	no	_
152-25	27941-27953	restrictions	_
152-26	27954-27956	on	_
152-27	27957-27960	the	_
152-28	27961-27966	usage	_
152-29	27967-27969	of	_
152-30	27970-27973	the	_
152-31	27974-27978	data	_
152-32	27979-27980	.	_

Text=We expect that users of the data will follow the ODC Attribution-Sharealike Community Norms (http: //opendatacommons.org/norms/odc-by-sa/), which state that any derivative works should be shared via an equally open license, and that the creators of this dataset should be credited by citation of the present data descriptor.
153-1	27981-27983	We	_
153-2	27984-27990	expect	_
153-3	27991-27995	that	_
153-4	27996-28001	users	_
153-5	28002-28004	of	_
153-6	28005-28008	the	_
153-7	28009-28013	data	_
153-8	28014-28018	will	_
153-9	28019-28025	follow	_
153-10	28026-28029	the	_
153-11	28030-28033	ODC	_
153-12	28034-28056	Attribution-Sharealike	_
153-13	28057-28066	Community	_
153-14	28067-28072	Norms	_
153-15	28073-28074	(	_
153-16	28075-28079	http	_
153-17	28080-28081	:	_
153-18	28082-28120	//opendatacommons.org/norms/odc-by-sa/	_
153-19	28121-28122	)	_
153-20	28123-28124	,	_
153-21	28125-28130	which	_
153-22	28131-28136	state	_
153-23	28137-28141	that	_
153-24	28142-28145	any	_
153-25	28146-28156	derivative	_
153-26	28157-28162	works	_
153-27	28163-28169	should	_
153-28	28170-28172	be	_
153-29	28173-28179	shared	_
153-30	28180-28183	via	_
153-31	28184-28186	an	_
153-32	28187-28194	equally	_
153-33	28195-28199	open	_
153-34	28200-28207	license	_
153-35	28208-28209	,	_
153-36	28210-28213	and	_
153-37	28214-28218	that	_
153-38	28219-28222	the	_
153-39	28223-28231	creators	_
153-40	28232-28234	of	_
153-41	28235-28239	this	_
153-42	28240-28247	dataset	_
153-43	28248-28254	should	_
153-44	28255-28257	be	_
153-45	28258-28266	credited	_
153-46	28267-28269	by	_
153-47	28270-28278	citation	_
153-48	28279-28281	of	_
153-49	28282-28285	the	_
153-50	28286-28293	present	_
153-51	28294-28298	data	_
153-52	28299-28309	descriptor	_
153-53	28310-28311	.	_

Text=We ask that users with questions please use the NeuroStars Forum (https: //neurostars.org) and attach the tags ‘ openfmri ’ and ‘ ds000030 ’ in order to discuss and comment on this dataset.
154-1	28312-28314	We	_
154-2	28315-28318	ask	_
154-3	28319-28323	that	_
154-4	28324-28329	users	_
154-5	28330-28334	with	_
154-6	28335-28344	questions	_
154-7	28345-28351	please	_
154-8	28352-28355	use	_
154-9	28356-28359	the	_
154-10	28360-28370	NeuroStars	_
154-11	28371-28376	Forum	_
154-12	28377-28378	(	_
154-13	28379-28384	https	_
154-14	28385-28386	:	_
154-15	28387-28403	//neurostars.org	_
154-16	28404-28405	)	_
154-17	28406-28409	and	_
154-18	28410-28416	attach	_
154-19	28417-28420	the	_
154-20	28421-28425	tags	_
154-21	28426-28427	‘	_
154-22	28428-28436	openfmri	_
154-23	28437-28438	’	_
154-24	28439-28442	and	_
154-25	28443-28444	‘	_
154-26	28445-28453	ds000030	_
154-27	28454-28455	’	_
154-28	28456-28458	in	_
154-29	28459-28464	order	_
154-30	28465-28467	to	_
154-31	28468-28475	discuss	_
154-32	28476-28479	and	_
154-33	28480-28487	comment	_
154-34	28488-28490	on	_
154-35	28491-28495	this	_
154-36	28496-28503	dataset	_
154-37	28504-28505	.	_

Text=Additional Information How to cite this article: Poldrack, R. A. et al.
155-1	28506-28516	Additional	_
155-2	28517-28528	Information	_
155-3	28529-28532	How	_
155-4	28533-28535	to	_
155-5	28536-28540	cite	_
155-6	28541-28545	this	_
155-7	28546-28553	article	_
155-8	28554-28555	:	_
155-9	28556-28564	Poldrack	_
155-10	28565-28566	,	_
155-11	28567-28569	R.	_
155-12	28570-28572	A.	_
155-13	28573-28575	et	_
155-14	28576-28578	al	_
155-15	28579-28580	.	_

Text=A phenome-wide examination of neural and cognitive function.
156-1	28581-28582	A	_
156-2	28583-28595	phenome-wide	_
156-3	28596-28607	examination	_
156-4	28608-28610	of	_
156-5	28611-28617	neural	_
156-6	28618-28621	and	_
156-7	28622-28631	cognitive	_
156-8	28632-28640	function	_
156-9	28641-28642	.	_

Text=Sci.
157-1	28643-28646	Sci	_
157-2	28647-28648	.	_

Text=Data 3:160110 doi: 10.1038/sdata.2016.110 (2016).
158-1	28649-28653	Data	_
158-2	28654-28662	3:160110	_
158-3	28663-28666	doi	_
158-4	28667-28668	:	_
158-5	28669-28691	10.1038/sdata.2016.110	_
158-6	28692-28693	(	_
158-7	28694-28698	2016	_
158-8	28699-28700	)	_
158-9	28701-28702	.	_

Text=Publisher ’ s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
159-1	28703-28712	Publisher	_
159-2	28713-28714	’	_
159-3	28715-28716	s	_
159-4	28717-28721	note	_
159-5	28722-28723	:	_
159-6	28724-28732	Springer	_
159-7	28733-28739	Nature	_
159-8	28740-28747	remains	_
159-9	28748-28755	neutral	_
159-10	28756-28760	with	_
159-11	28761-28767	regard	_
159-12	28768-28770	to	_
159-13	28771-28785	jurisdictional	_
159-14	28786-28792	claims	_
159-15	28793-28795	in	_
159-16	28796-28805	published	_
159-17	28806-28810	maps	_
159-18	28811-28814	and	_
159-19	28815-28828	institutional	_
159-20	28829-28841	affiliations	_
159-21	28842-28843	.	_

